Serological Techniques for Detection of Antibodies  Against Peste des Petits Ruminants Virus by Abd-El razig, Sana
ﻡﻴﺤﺭﻟﺍ ﻥﻤﺤﺭﻟﺍ ﷲﺍ ﻡﺴﺒ 
 
Serological Techniques for Detection of Antibodies 
Against Peste des Petits Ruminants Virus  
 
By 
Sana Abd-El razig Rhamtalla Mohammed 
B.V. Sc (University of Bahr El Ghazal.2004) 
 
  Supervisor: 
Dr. Suliman Mohammed El Hassan 
  
 
A thesis submitted to the University of Khartoum in partial fulfillment 
of the requirements for the degree of Master Science in  
  Microbiology  
 
 
 
Department of Microbiology 
Faculty of Veterinary Medicine  
University of Khartoum 
 
 
November 2009                                                            
 
 
 ﺑﺴﻢ ﺍﷲ ﺍﻟﺮﺣﻤﻦ ﺍﻟﺮﺣﻴﻢ
 
 
  (ﻯ ﻋﻠﻢ ﻋﻠﻴﻢﺫﻛﻞ ﻭﻓﻮﻕ ) :ﻗﺎل ﺗﻌﺎﻟﻰ
 ﺻﺪق اﷲ اﻟﻌﻈﻴﻢ
 
  (67 اﻵﻳﺔ)ﻳﻮﺳﻒﺳﻮرة 
 
 
 
 
 
 
 
 
 
 
 
 
 
i 
 
 
DEDICATION 
 
 
 
 
This work is dedicated 
 To 
       
To my beloved Parents 
Sisters, brothers and friends 
 
 
 
 
 
 ii
 ACKNOWLEGMWNTS  
 
First of all my thanks to Almighty Allah for giving me the 
strength, and willpower to the accomplishment of this study. 
I would like to thank my supervisor Dr. Sulaiman Mohammed El 
Hassan, Department of Microbiology, Faculty of Veterinary Medicine, 
University of Khartoum for his help and advice.  
My gratitude is extended to Dr Mohammed Abdalla Fadol, viral 
vaccines production complex, Central Veterinary Research Laboratory 
(CVRL) for his help and advice. 
Special thanks to Dr Abd Elgadir Ballal. Head Department of 
Viral Vaccines Production complex, Central Veterinary Research 
Laboratory (CVRL), and staff of the department for their unlimited help, 
and advice.  
My gratitude is extended to Professor Mahasin El nur Abdel 
Rhaman, Head Department of Virology, Central Veterinary Research 
Laboratory (CVRL) for her help in carrying out the c ELISA. 
My gratitude is extended to the Director of the Central Veterinary 
Research Laboratory (CVRL) Soba for his permission to carry out this 
work in the Central Veterinary Research Laboratory.     
Also, I would like to express my deep sense to everyone who helped 
me to carry out this work. 
  
 
 
 
 iii
 
TABLE OF CONTENTS 
 
CONTENTS Page 
No. 
Dedication……………………………………………………………………... i 
Acknowledgements………………………………………………..................... ii 
Table of contents…………………………………………………..................... iii 
List of tables…………………………………………………………………… vii 
List of figures…………………………………………………………….......... viii 
English abstract……………………………………………………………....... ix 
Arabic abstract……………………………………………………………….... x 
Introduction……………………………………………………………………. 1 
.CHAPTER ONE:  LITERATURE REVIEW……………………………… 3 
1.1    History of the disease…………………………………………………... 3  
1.1.1        PPR in Sudan……………………………………………………  3 
1.2 Etiology………………………………………………………….. 4 
 1.2.1 Classification of the virus……………………………………. 4 
 1.2.2   Virion properties…………………………………………………..  5  
1.3 Viral replication…………………………………………………… 6 
1.3.1 Adsorption and penetration...…………………………………….   7 
 1.3.2 Transcription, translation and replication of RNA……………… 7 
1.3.3 Assembly…………………………………………………………. 7 
1.3.4 Role of neuraminidase…………………………………………..... 8 
1.3.5 Activation of the F protein………………………………………. 8 
1.4 Physico-chemical properties………………………………………. 8 
    1.5 Epidemiology…………………………………………………... 9 
 1.5.1 Host range………………………………………………………… 9 
 iiii
 1.5.2 Geographic   distribution…………………………………………. 9 
 1.5.3. Transmission…………………………………………………….. 10 
   1.6 Clinical features…………………………………………………. 11 
   1.7  Pathogenencsis…………………………………………………… 12 
   1.8  Histopathology…………………………………………………… 13 
   1.9 The gross lesions………………………………………………… 13 
   1.10 Diagnosis…………………………………………………………  14 
  1.10.1 Field diagnosis…………………………………………………… 14 
  1.10.2 Laboratory diagnosis…………………………………………….. 14 
    
1.10.2.1 
Specimens for laboratory diagnosis ………………………………  14 
1.11 Serological test for detection of PPR antigens…………………... 15  
    1.11.1 Immunocapture enzyme–linked immunosorbent assay (ELISA). 15 
    1.11.2 Counterimmunoelectrophoresis (CIEP)…………………………. 15  
    1.11.3 Agar gel immunodiffusion (AGID) test…………………………. 16 
    1.11.4 Virus neutralization test………………………………………….. 16 
1.12.  Routine serological tests………………………………………… 17 
     1.13. Molecular diagnosis……………………………………………… 17 
      1.13.1 Nucleic acid recognition methods……………………………….. 17 
      1.13.2 Polymerase chain reaction PCR…………………………………. 17 
    1.14 Virus isolation……………………………………………………. 17 
    1.15 Differential diagnosis……………………………………………. 18 
    1.16 Control……………………………………………………………. 18 
    1.16.1 Treatment………………………………………………………….  18 
      1.16.2 Vaccination……………………………………………………….. 18 
      1.16.3 Control and eradication…………………………………………... 19 
     1.17 Public health……………………………………………………… 19 
CHAPTER TWO: MATERIALS AND METHODS…………………….... 20 
 iiv
2.1   
  2.2  
Preparation and sterilization of glassware…………………………. 
    Sera    …………………………………………………………… 
    20 
    20  
    2.2.1 Serum samples…………………………………………………….. 20 
     2.2.2 Hyperimmune serum (Positive control)…………………………… 20 
       2.2.3  New borne calf serum (sigma) (Negative control)………………… 20 
2.3 Cell culture ……………………………………………………….. 21 
       2.3.1  Cell culture preparation…………………………………………. 21 
2.4 PPR Virus…………………………………………………………. 21 
    2.5 Serological tests…………………………………………………… 21 
    2.5.1 Agar gel immunodiffusion test…………………………………… 21 
    2.5.1.1  Preparation of agar………………………………………………... 21 
    2.5.1.2 Preparation of PPR virus antigen…………………………………. 23 
    2.5.1.3 Test procedure……………………………………………………... 23 
  2.5.2 Serum Neutralization test (SNT)…………………………………. 24 
    2.5.2.1 Test procedure……………………………………………………… 24 
  2.5.3 Competitive   ELISA………………………………………………. 24 
    2.5.3.1 Principle of the test………………………………………………… 24 
    2.5.3.2 Antigen……………………………………………………………... 25 
    2.5.3.3 Control sera………………………………………………………… 25 
    2.5.3.4 Monoclonal antibody (MAb)………………………………………. 25 
    2.5.3.5 Anti species conjugate……………………………………………... 25 
 2.5.4 Reagents…………………………………………………………… 25 
 2.5.4.1 Coating buffer (phosphate buffer saline (PBS))………………….. 25 
 2.5.4.2 Washing buffer (WB)……………………………………………… 25 
 2.5.4.3 Blocking buffer (BB)………………………………………………. 26 
 2.5.4.4 Chromogen-substrate solution…………………………………….. 26 
 2.5.5 Test procedure……………………………………………………… 26 
 2.6 Data analysis……………………………………………………….. 27 
 iv
2.6.1 Principle of parameters…………………………………………….. 27 
2.6.2 Statistical analysis………………………………………………….. 28 
CHAPTER THREE: RESULTS  
3.1. Examination of the sera by agar gel immunodiffusion (AGID) test 31 
3.2. Examination of the sera by neutralization test (SNT)……………… 31 
3.3 Examination of the sera by cELISA test…………………………… 31 
3.4 Comparison between cELISA, SNT and AGID tests……………… 31 
CHAPTER FOUR: DISCUSSION………………………………………....... 40 
CONCLUSION……………………………………………………………...... 44 
RECOMMENDATIONS……………………………………………………... 45 
REFERENCES………………………………………………………………….. 
APPENDICES….…………………………………………………………………
  46 
   57 
   Buffers ………………………………………………………………  57 
1 Physiological saline (Normal Saline) 0.85%………………………….  57 
2 Phosphate buffered saline (PBS)……………………………………...  57 
       3 Phosphate diluents (PD)………………………………………….........  57 
   Cell dispersing solutions…………………………………………........  58 
  1    Trypsin (7.5%)………………………………………………………...  58 
   2 Veresene (5%)………………………………………………………… 58 
    3  Trypsin versene solution…………………………………………........ 58 
 Tissue culture media………………………………………………….. 58 
 1 Growth media……………………………………………………........ 58 
 2 Maintenance medium……………………………………………......... 59 
 Media additives……………………………………………………. 59 
 1 Lactalbumin hydrolystate (5%)………………………………………. 59 
  2 Sodium bicarbonate 7.5% (NaHCO3)……………………………....... 59 
 
  
 
 ivi
LIST OF TABLES 
 
 
 
 
 
 
 
 
 
 
 
 
Table 
No. 
Title Page 
No. 
1 Serum samples collected from sheep and goats from 
different localities in Sudan for serological detection 
of PPRV antibodies. 
 
22 
2 Detection of PPRV antibodies in 400 serum samples 
collected from sheep and goats in different localities 
by AGID and virus neutralization test (SNT). 
 
33 
3 Detection of PPRV antibodies in 266 serum samples 
collected from sheep and goats in different localities 
by cELISA test. 
 
34 
4 PPRV seropositive serum samples collected from 
goats and sheep in different localities in Sudan 
detected by NT, AGID and cELISA tests (n=266). 
 
35 
5 PPRV antibodies detection by agar gel-
immunodiffusion test in relation to cELISA test 
(n=266). 
 
36 
6 PPRV antibodies detection by neutralization test in 
relation to cELISA test (n=266) 
 
37 
7 The Sensitivity, specificity, positive predictive value, 
negative predictive value and efficiency of NT and 
AGID tests in relation to cELISA test (n=266). 
48 
 ivii
LIST OF FIGURES 
 
 
Page 
No. 
Title Figure  
No. 
29 The different arrangements of Ag and hyperimmune 
serum and serum samples in agar gel immundiffusion 
test. 
 
1 
   
30       cELISA Plate layout   
                                        
2 
39  Frequency of sropositive and seronegative PPRV 
antibodies detected by AGID test, NT and cELISA test 
in serum samples of sheep and goats (n=266).  
  
3 
    
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iviii
 
ABSTRACT 
  Peste des petits ruminants (PPR) is acute disease of sheep and 
goats. The disease is highly contagious and causes varying degree of 
morbidity and mortality. In Sudan, the disease is endemic resulting in 
heavy economic loss.   The objective was to assess the seropositvity of 
PPR virus antibodies in sheep and goats and to evaluate sensitivity and 
specificity of agar gel immunodiffusion test (AGID) and serum 
neutralization test (NT) in relation to competitive immunocapture 
enzyme–linked immunosorbent assay (cELISA). A total of 400 serum 
samples collected from sheep and goats were screened for PPR virus 
antibodies by AGID test and NT. Out of these 400 samples, 266 were 
screened by cELISA test.  
The overall PPR virus antibodies serosurveillance recorded in 
sheep and goats was 25.75%, 41.75% and 51.87% by AGID test, NT and 
cELISA test, respectively.  
cELISA proved be amore sensitive test than AGID and NT tests, 
and this confirms previous studies which proved  that cELISA is efficient, 
sensitive and specific diagnostic technique for detection of PPRV 
antibodies. When AGID and NT test were evaluated in relation to 
cELISA, statistical analysis showed NT had higher sensitivity than AGID 
test but lower specificity in relation to cELISA. This indicates that NT is 
the second test of choice for detection of PPRV antibodies. 
The present investigation confirms previous studies in detection 
PPRV antibodies in serum samples of sheep and goats with no 
vaccination history. This indicates the exposure of sheep and goats to 
PPR virus and the disease remains prevalent in Sudan.     
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  ﺺ ﻠﺨﺴﺘﻤاﻟ
 ﻣﺮض ﻃﺎﻋﻮن اﻟﻤﺠﺘﺮات اﻟﺼﻐﻴﺮة ﻣﺮض ﺣﺎد اﻹﺻﺎﺑﺔ ﻓﻰ اﻟﻀﺄن واﻟﻤﺎﻋﺰ ﺷﺪﻳﺪ 
ﺴﺘﻮﻃﻨﺔ ﻓﻰ ﻣﻦ اﻷﻣﺮاض اﻟﻤوﻳﻌﺪ . اﻟﻌﺪوى وﻳﺴﺒﺐ درﺟﺎت ﻣﺘﻔﺎوﺗﺔ ﻣﻦ اﻹﺻﺎﺑﺔ واﻟﻨﻔﻮق 
ﻳﻢ إﻳﺠﺎﺑﻴﺔ اﻷﺟﺴﺎم ﻮوﻗﺪ أﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻟﺘﻘ. اﻟﺴﻮدان وﻳﺘﺴﺒﺐ ﻓﻰ ﺧﺴﺎﺋﺮ إﻗﺘﺼﺎدﻳﺔ ﻋﺎﻟﻴﺔ 
ﻳﻢ ﻮو ﻟﺘﻘ، ﻮن اﻟﻤﺠﺘﺮات اﻟﺼﻐﻴﺮة دﻣﺎء اﻟﻀﺄن واﻟﻤﺎﻋﺰ ﻟﻔﻴﺮوس ﻃﺎﻋ ﻣﻦلﺎﻣﺼأاﻟﻤﻀﺎدة ﻓﻰ 
ﺎرﻧﻪ وإﺧﺘﺒﺎر اﻟﺘﻌﺎدل اﻟﻤﺼﻠﻰ ﻣﻘ( اﻟﻬﻼم)ﺣﺴﺎﺳﻴﺔ وﻧﻮﻋﻴﺔ إﺧﺘﺒﺎر اﻹﻧﺘﺸﺎر اﻟﻤﻨﺎﻋﻰ ﻓﻰ اﻷﺟﺎر
  .ﺑﺈﺧﺘﺒﺎر اﻻﻟﻴﺰا اﻟﺘﻨﺎﻓﺴﻴﺔ
وس ﻃﺎﻋﻮن  ﻟﻔﻴﺮﺿﺪادﻌﺖ ﻣﻦ اﻟﻀﺄن واﻟﻤﺎﻋﺰ ﻟﻠﻜﺸﻒ ﻋﻦ اﻷ ﻋﻴﻨﺔ ﻣﺼﻞ ﺟﻤ004 ﺖﻓﺤﺼ
 ﺖﻓﺤﺼو.   إﺧﺘﺒﺎري اﻹﻧﺘﺸﺎر اﻟﻤﻨﺎﻋﻰ ﻓﻰ اﻟﻬﻼم واﻟﺘﻌﺎدل اﻟﻤﺼﻠﻰﺎﺟﺮاءاﻟﻤﺠﺘﺮات اﻟﺼﻐﻴﺮة ﺑ
 ﺿﺪادﺘﺸﺎر اﻷآﺎن ﻣﻌﺪل إﻧ.  ﻨﺎﻓﺴﺒﺔ ﻋﻴﻨﺔ ﻣﻦ اﻟﻤﺠﻤﻮع اﻟﻜﻠﻰ ﺑﻮاﺳﻄﺔ إﺧﺘﺒﺎر اﻹﻟﻴﺰا اﻟﺘ662
ﺑﻮاﺳﻄﺔ إﺧﺘﺒﺎر اﻹﻧﺘﺸﺎر اﻟﻤﻨﺎﻋﻰ % 78.15، %57.14، %57.52ﻟﻠﻔﻴﺮوس ﻓﻰ اﻟﻀﺄن واﻟﻤﺎﻋﺰ 
  . ﻓﻰ اﻟﻬﻼم  واﻟﺘﻌﺎدل اﻟﻤﺼﻠﻰ واﻹﻟﻴﺰا اﻟﺘﻨﺎﻓﺴﻴﺔ ﻋﻠﻰ اﻟﺘﻮاﻟﻰ
آﺸﻔﺖ اﻟﺪراﺳﺔ أن إﺧﺘﺒﺎر اﻹﻟﻴﺰا اﻟﺘﻨﺎﻓﺴﻴﺔ أآﺜﺮ ﺣﺴﺎﺳﻴﺔ ﻣﻦ إﺧﺘﺒﺎرى اﻹﻧﺘﺸﺎر اﻟﻤﻨﺎﻋﻰ 
 اﻟﺪراﺳﺎت اﻟﺴﺎﺑﻘﺔ ﺘﻮاﻓﻖ ﻣﻊ  ﻣﻤﺎ ﻳسﻟﻠﻔﻴﺮو ﺿﺪاد اﻷ ﻓﻰ اﻟﻬﻼم واﻟﺘﻌﺎدل اﻟﻤﺼﻠﻰ ﻓﻰ اﻟﻜﺸﻒ ﻋﻦ
ﻒ اﻟﺘﻰ أﺛﺒﺘﺖ أن ﺗﻘﻨﻴﺔ اﻟﺘﺸﺨﻴﺺ ﺑﻮاﺳﻄﺔ اﻹﻟﻴﺰا اﻟﺘﻨﺎﻓﺴﻴﺔ أآﺜﺮ ﺣﺴﺎﺳﻴﺔ وﻓﻌﺎﻟﻴﺔ ودﻗﺔ ﻓﻰ اﻟﻜﺸ
  . ﻟﻠﻔﻴﺮوسﺿﺪادﻦ اﻷﻋ
أﻇﻬﺮ اﻟﺘﺤﻠﻴﻞ اﻹﺣﺼﺎﺋﻰ ﻟﻨﺘﺎﺋﺞ اﻟﺪراﺳﺔ أن إﺧﺘﺒﺎر اﻟﺘﻌﺎدل اﻟﻤﺼﻠﻰ أآﺜﺮ ﺣﺴﺎﺳﻴﺔ ﻣﻦ 
إﺧﺘﺒﺎر اﻹﻧﺘﺸﺎر اﻟﻤﻨﺎﻋﻰ ﻓﻰ اﻟﻬﻼم وﻟﻜﻨﻪ أﻗﻞ ﻧﻮﻋﻴﺔ  ﻣﻘﺎرﻧﺔ ﻣﻊ إﺧﺘﺒﺎر اﻹﻟﻴﺰا اﻟﺘﻨﺎﻓﺴﻴﺔ ﻣﻤﺎ ﻳﺸﻴﺮ 
  .ﻟﻠﻔﻴﺮوس ﺿﺪادإﻟﻰ أن إﺧﺘﺒﺎر اﻟﺘﻌﺎدل اﻟﻤﺼﻠﻰ هﻮ اﻹﺧﺘﺒﺎر اﻟﺜﺎﻧﻰ ﻟﻠﻜﺸﻒ ﻋﻦ اﻷ
 اﻟﻀﺄن  ﻣﻦلﺎﻣﺼأ ﻟﻠﻔﻴﺮوس ﻓﻰ ﺿﺪادﻘﺔ اﻟﺘﻰ ﺗﻘﺼﺖ ﻋﻦ اﻷ اﻟﺒﺤﻮث اﻟﺴﺎﺑﺔأآﺪت اﻟﺪراﺳ
 ﻟﻔﻴﺮوس  ﻧﺎتا ﻣﻤﺎ ﻳﺸﻴﺮ إﻟﻰ ﺗﻌﺮض هﺬﻩ اﻟﺤﻴﻮواﻟﻤﺎﻋﺰ اﻟﺘﻰ ﻟﻢ ﻳﺴﺒﻖ ﺗﺤﺼﻴﻨﻬﺎ ﺿﺪ اﻟﻤﺮض
  . اﻟﺴﻮدانﻃﺎﻋﻮن اﻟﻤﺠﺘﺮات اﻟﺼﻐﻴﺮة وإﻧﺘﺸﺎر اﻟﻤﺮض ﻓﻰ
 
 
 
INTRODUCTION 
Peste des petits ruminants (PPR) is a highly contagious systemic 
viral disease of goats and sheep. Infected animals present clinical signs 
similar to those of rinderpest in cattle from which it must be 
differentiated, and caused by closely related morbillivirus. Unlike 
rinderpest, however many infections are subclinical.  
PPR is known as goat plaque and it is referred to as kata in Nigeria 
and as pseudo rinderpest (Otte, 1960; Rowland and Bourdin, 1970; 
Hamdy et al., 1976). The course of the disease may be peracute acute or 
chronic, however the virus does not persist. PPR is often rendered more 
severe by secondary bacterial infections, concomitant helminthiasis, 
which has led to the introduction of descriptive term stomatitis-
pneumonterits complex (Fenner et al., 1987). It occurs mainly in West 
Africa, although outbreaks have also been described elsewhere .The 
disease is characterized by high fever, ocular and nasal discharge, 
pneumonia, necrosis and ulceration of the mucous membrane and 
inflammation of gastro-intestinal tract leading to severe diarrhea, clinical 
signs develop after incubation period of 3-10 days (Gibbs et al., 1979). 
The disease is highly contagious causing varying degree of morbidity and 
mortality in susceptible animals (Radostits et al., 2000). Morbidity and 
mortality rates can be as high as 100 and 90 per cent, respectively (Abu-
Elzien et al., 1990). Mortality rates usually lower in endemic areas and 
mortality can be as low as 20% and serosurveillance is sometimes the 
only indicator of infection (Roeder and Obi, 1999). 
In the basis of mortalities, morbidity, PPR has great economic 
importance through body wastage, poor feed efficiency, loss meat, milk 
and offspring (Nawathe, 1984). Although PPR remains the principal 
killing disease of small ruminants in most Africa, Asia and Middle East 
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countries as recognized in international survey report published in 2002 
(Perry et al ., 2002), few economic studies have been made on this 
disease. The most recent one was published in 1992, it was conducted in 
Nigeria (Chip, 1993). 
PPR is an important disease in its own right, but it has also created 
problems because of its apparent similarity to rinderpest. The clinical 
signs of PPR closely resemble those of rinderpest, making differential 
diagnosis difficult. It should, however, be borne in mind that clinical 
disease caused by rinderpest in small ruminants is a relatively rare event, 
even in Asia. PPR is considered to be one of the main constraints to 
improving productivity of small ruminants in the regions where it is 
endemic (Ikede, 1983).      
  In Sudan PPR have been reported in 1971(El Hag, 1973; El Hag 
and Taylor, 1984). The rinderpest (RP) tissue culture vaccine used to 
control the occurrence of the epizootics of the disease based on the 
principal of antigenic relationship that exists between PPR and RP viruses 
(El Hag, 1973). The use of rinderpest vaccine against PPR was avoided in 
Sudan when rinderpest seromonitoring studies were performed. Recently, 
PPR attenuated virus vaccine for control of PPR disease is produced in 
Sudan at the CVRL. 
The objectives of this investigation were 
1- To continues the study of the PPR disease that done by Intisar 
(2002),and  cover different localities in Sudan by different serological 
tests. 
2- To compare sensitivity and specificity of serological tests, and to select 
the most reliable test to be applied for monitoring of PPR antibodies.  
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CHAPTER ONE 
LITERATURE REVIEW 
1.1. History of the disease 
PPR has comparatively a shorter history which only dates back to 
1940, when it was first identified as a distinct disease by Francophone 
workers in Benin and Senegal and described by Cathou in Benin and 
Gargdennec and Lananne in Ivory Coast of West Africa (1942). PPR 
existence was associated with West Africa countries, where the disease 
known as pest des petits ruminant.  
Zwart and Rowe (1966) found neutralizing antibodies to rinderpest virus 
in sera from goats and sheep in northern Nigeria and interpreted this to 
suggest the presence of PPR in Nigeria(Obi, 1984). Also Whitney et al. 
(1967) described a disease known as Kata in south western Nigeria. Later 
Rowland and Bourdin (1970) and Rowland  et al. (1971) found that PPR 
and Kata were clinically and pathologically indistinguishable and then in 
Nigeria the disease was reported by Isoun and Maun (1972), Nduakas and 
Ihemalanuss (1973), and Hamdy et al. (1976). After development of 
specific diagnostic tools in late 1980s on wards, the understanding of the 
distribution of PPR has grown very quickly (Diallo et al., 1995) and 
recent data indicates the presence of PPRV in all countries of Africa. In 
India PPR was first confirmed in sheep suspected of having rinderpest. It 
is believed since then that many outbreak in India previously attributed  
to rinderpest were actually PPR (Taylor, 2002).  
1.1.1. PPR in Sudan 
  In Sudan, outbreak of rinderpest involving goats and sheep and 
cattle in eastern Sudan was investigated in 1971, and the antigen which 
was isolated from this outbreak produced a positive reaction in immune 
tests with rinderpest hyperimmune serum. The presence of rinderpest 
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immune serum in the culture medium inhibited the isolation of an antigen 
which produced cytopathic effects charactererised by the production of 
syncytia. For these reasons the outbreaks were originally diagnosed as 
rinderpest but new evidence presented suggests they were probably due to 
PPRV which was repeatedly isolated by El Hag (1973) and El Hag and 
Taylor (1984). 
1.2 Etiology 
The causative agent of this economically important disease of 
small ruminants is Peste de petits ruminants virus (PPRV). This virus 
belongs to the genus Morbillivirus, under the family Paramyxoviridae of 
the order Mononegavirales (Murphy et al., 1999). The virus is closely 
related to Rinderpest virus (RPV), another member of Morbillivirus 
genus, which causes similar disease in large ruminants (Anderson et al., 
1990; Couacy-Hyman et al., 1995). The virus is also serologically related 
to measles and canine distemper virus and phocid distemper virus (PDV) 
of sea mammals (seals) (Gibbs et al., 1979). 
For many years, PPR, virus was considered a variant of RPV, specifically 
adapted for goats and sheep that had lost its virulence for cattle. It is now 
known that the two viruses are distinct though closely related 
antigenically (Gibbs et al; 1979, Appel et al; 1981). 
1.2.1 Classification of the virus 
  On the basis of it’s similarity to viruses of rinderpest, canine 
distemper and measles, the PPR virus has been classified within the genus 
morbillivirus in the family paramyxoviridae which included the 
etiological agents of the most important Veterinary diseases: Canine 
distemper, rinderpest of cattle and Newcastle disease of chicken. It is 
subdivided into three genera, paramyxovirus, morbillvirus and 
pneumovirius . The virus of the genera paramyxovirus and pneumovirus 
caused respiratory infections and occasionally generalized infections.  
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Viruses of the genus Morbillvirus usually cause generalized infection: 
Rinderpest of cattle, peste des ruminants of sheep and goats, and canine 
distemper as well as measles (Fenner et al., 1987). 
1.2.2. Virion properties 
The ultra structure of PPR virus has been examined by electron-
microscope using negative staining technique. The virus particle was 
found to be pleomorphic in shape (spherical as well as filamentous forms 
occur) 130-390 nm in diameter. Virions are enveloped, covered with 
large peplomers 8-15 nm in length, and contain a herringbone-shaped, 
helically symmetrical nucleocapsid , 600-800 nm n length and 14-23 nm 
in diameter (Durojaiye et al., 1985). The genome consists of a single 
linear molecule of negative-sense, single-stranded RNA 15-16 kb in size. 
There are 6 to 10 genes separated by conserved noncoding sequences that 
contain termination, polyadenylation, and initiation signals. Most of gene 
products are structural proteins found in virions. The peplomers are 
composed of two glycoproteins a hemagglutinin-neuraminidase protein 
(HN) and a fusion protein (F). Both proteins play key roles in the 
pathogenesis of all paramyxovirus infections. Hemagglutination involves 
the agglutination of red blood cells. It relies on the ability of a virus to 
bind to receptors on red blood cells. Since viruses have multiple 
attachment proteins per virion, they can bind to more than one red blood 
cell and so they can serve to link red blood cells into a network. 
Inactivated virus can still hemagglutinate as long as its attachment 
proteins are intact. If someone has antibodies to a viral hemagglutinin, the 
antibodies will binds to the attachment protein and prevent its binding to 
the red blood cells. The serum of that person will  
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inhibit the agglutination reaction by the virus to which they have 
antibodies, but not by other hemagglutinating viruses. This can be used to 
determine which hemagglutinating virus a person has been exposed to 
(Hunt, 2008). Hemadsorption during infection, the viral attachment 
protein will be inserted into the plasma membrane of the infected cell. If 
the viral attachment protein can bind to red blood cells, the infected cell 
will bind red blood cells because it has the viral attachment protein on its 
surface, this is called hemadsorption. In the clinical laboratory, this may 
enable virally-infected cells to be detected at an early stage in infection, 
and may allow detection of viruses which do not visibly damage the cell 
(Hunt, 2008). The genome of attenuated vaccine strain of PPRV (Nigeria 
75/1) has entirely been sequenced and the physical map of the genome is 
the same as that of the other morbilliviruses (Rima et al., 1986; Diallo et 
al., 1990). Although, there is only one serotype of the virus (Barrett et al., 
1993), PPRV isolates on the basis of partial sequence analysis of the 
fusion (F) protein gene, can be grouped into four distinct lineages. 
Lineage 1 and 2 are found exclusively in West Africa, whereas lineage 3 
has been found in eastern Africa and Arabia. The fourth lineage is 
confined exclusively in the Middle East, Arabia and Indian subcontinent 
(Shaila et al., 1996). Except one isolate (TN92/1) from southern India, 
which belonged to lineage 3, all Indian PPRV isolates identified so far 
belonged to lineage 4 only (Nanda et al., 1996; Dhar et al., 2002). 
1.3. Viral replication 
The PPR virus has cytoplasmic replication. The none segmented 
negative -sense, single- stranded RNA of paramyxovirus carries RNA-
dependant RNA polymerase, transcriptase, which transcribes five or more 
subgenomic positive sense RNAs, each of which serves as 
amonocistronic mRNA in contrast, transcription in the replication mode 
(by the same polymerase acting as a replicases) produce a full- length 
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positive template for the synthesis of new negative sense viral RNA. The 
envelope of the new generation of the virus acquired during   the budding 
from the plasma membrane. Eclipse period is 4 hours (Frederick et al., 
1999). 
1.3.1. Adsorption and penetration   
The H (N) G protein recognize receptors on cell surface. The F 
protein facilitates fusion between membranes at physiological pH, so 
although paramyxoviruses can be taken up by endocytosis, they also 
often enter the cell by direct fusion with the plasma membrane . Because 
the F protein functions at physiological pH, this can result in syncytia 
being formed in paramyxovirus infections (Hunt, 2008). 
1.3.2. Transcription, translation and replication of RNA  
Viral multiplication occurs in the cytoplasm. The viral RNA 
polymerase uses the nucleocapsid as a template. The RNA polymerase 
does not need a fully uncoated nucleocapsid. Viral mRNAs are 
transcribed; these are capped, methylated and polyadenylated. Since this 
is a negative-strand RNA virus, RNA polymerase and RNA modification 
enzymes are packaged in the virion. The viral mRNAs are translated to 
give viral proteins. There is no distinction between early and late 
functions in gene expression. Viral RNA replication involves full length 
plus strand synthesis. This is used as a template for full length minus 
strand. Both full length strands are coated with nucleocapsid protein as 
they are made . New full length minus strands may serve as templates for 
replication, or templates for transcription, or they may be packaged into 
new virions.  
 1.3.3. Assembly  
Both viral glycoproteins i.e. attachment protein and F (fusion) 
protein) are translated as transmembrane proteins and transported to the 
cell plasma membrane. M (matrix) protein enables nucleocapsids to 
 8
interact with the regions of the plasma membrane which have the 
glycoproteins inserted. The virus buds out through membrane (Hunt, 
2008).  
1.3.4. Role of neuraminidase 
In those paramyxoviruses which have neuraminidase, the neuraminidase 
may facilitate release. In these viruses, sialic acid appears to be an 
important part of the receptor. The neuraminidase removes sialic acid 
(neuraminic acid) from the cell surface. Thus, since sialic acid will have 
been largely removed from the cell surface and the progeny virions, 
neither will have functional receptors, so progeny virions will not stick to 
each other nor to the cell, they have just budded out from infected cell. 
They will therefore be able to diffuse away until they meet an uninfected 
cell. The neuraminidase may also help during infection since, if the virus 
binds to sialic acid residues in mucus, it would not be able to bind to a 
receptor on a cell and infect that cell. But if the sialic acid in the mucus is 
eventually destroyed, the virus will be freed and may then reach a 
receptor on the cell surface (Hunt, 2008).  
1.3.5. Activation of the F protein 
The F protein needs to be cleaved before it can function in 
facilitating fusion when the virus binds to another cell. This is a late event 
in maturation (Hunt, 2008). 
 1.4. Physico-chemical properties  
PPR virus may survive at 60oC for 60 minutes, and it is stable 
between pH 7.2 -7.9 but is rapidly inactivated at pH values less than 5.6 
or greater 9.6 (Lefever, 1982). Possible airborne spread the virus over 
several hundred meters, mainly at night. High and low humidity aid 
survival but virus is rapidly destroyed at relative humidity 50–60%. 
Contaminated pastures would be non-infective after 6–24 hours, 
depending on sun/shade (FAO, 1999) 
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The infectivity of enveloped viruses is readily destroyed by lipid solvent 
such as ether alcohol, chloroform, and detergent like phenol as well as by 
most disinfectants e.g. Glutaraldehyde is excellent disinfectant, sodium 
deoxycholate  and sodium hydroxide 2% (24 hours), sodium carbonate 
are very effective against PPR virus. Anderson (1999) stated that the 
virus might survival long time in chilled and frozen tissue. 
1.5. Epidemiology 
1.5.1. Host range 
PPR is a primarily disease of goats and sheep .Goats are usually 
more severely affected than sheep and involve goats of all ages (Singh et 
al., 2000). There have been several reports of PPR occurring in captive 
wild ungulates from the following families: Gazellinae (Dorcas gazelle), 
ibex (Capra inbex nubiana, laristan sheep) and gemsbok (Oryx gazelle) 
(Saliki, 2002). 
Experimentally, the American white–taild deer (Odocoileus virginianus) 
is fully susceptible to PPR. The role of a wild life on the epizootiology of 
the PPR in Africa should be investigated (Taylor, 1984).  
Cattle, buffaloes, camels, and pigs are also susceptible to infection but do 
not exhibit clinical signs and are unable to transmit the disease to other 
animal (Taylor, 1984). PPRV was also suspected to be involved in the 
epizootic disease that affected single humped camels in Ethiopia in 1995–
1996 (Roger et al., 2000, Roger et al., 2001). The isolation of virus from 
an outbreak in Indian buffalo (Bubalus bubalis) has been reported 
(Govindarajan et al., 1997). 
1.5.2 Geographic   distribution 
PPR has comparatively a shorter history which only dates back to 
1940, when it was first described by Gargadennec and Lalane (1942) in 
Ivory Coast of West Africa. For a long time, its existence was associated 
with west African countries. After development of specific diagnostic 
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tools in late 1980s onwards, the understanding of the geographical 
distribution of PPR has grown very quickly (Diallo et al., 1995) and 
recent data indicates the activity of PPRV in all countries of Africa lying 
between Sahara and the Equator. It has been reported in Sudan (El hag 
and Taylor, 1984), Kenya, Uganda (Wamwayi et al., 1995) and also in 
Ethiopia (Roeder et al., 2002). The disease has been seen in Arabian 
Peninsula and the Middle East including Islamic Republic of  Iran, Iraq, 
Israel, Jordan, Kuwait, Lebanon, Oman, Saudi Arabia, the United Arab 
Emirates and Yemen (Dhar, 2002), with extension to Turkey, and 
Pakistan. In India PPR was first reported in 1987 from Tamil Nadu 
(Shaila et al., 1989). Outbreaks of PPR are now known to be common in 
Bangladesh and Nepal (Shaila et al., 1996; Dhar et al., 2002; Taylor et 
al., 2001). In Africa and Asia the disease is particularly devastating, as 
these countries often use small ruminants as components of agricultural 
food production (Ozkul et al., 2002). 
PPRV was repeatedly isolated in Sudan by El Hag (1973); El Hag and 
Taylor (1984); Rasheed (1992); Zeidan (1992); Awad El Karim et al. 
(1994) and El Amin and Hassan (1998);Intisar (2002); Nussieba (2005); 
Abu Obieda (2006).  
1.5.3. Transmission  
For PPR to spread it requires close contact between infected and 
susceptible animals (Ozkul, 2002). Saliki. (2002) stated that, there are 
several means of transmission between animals. The disease is 
transmitted by inhalation of aerosols produced by sneezing and coughing 
of infected animals living in close contact, or by contamination of the 
food and water by the main sources of the virus which are ocular, nasal, 
or oral secretions. Feces, urine, milk and products of abortion contain 
large amounts of the virus. Fine infective droplets are released into the air 
from these secretions and excretions. During the rainy season or dry cold 
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season PPR outbreaks are more frequent. Fomite such as bedding, water 
and feed trough may also contribute to the onset of an outbreak. In the 
few animals that do recover, there is no “carrier” state but milk may be 
infectious 45 days after clinical recovery. 
The appearance of clinical PPR may be associated with any of the 
following: History of recent movement or gathering together of sheep 
and/or goats of different ages with or without associated changes in 
housing and feeding; introduction of recently purchased animals; contact 
in a closed/village flock with sheep and/or goats that had been sent to 
market but returned unsold; change in weather such as the onset of the 
rainy season (hot and humid) or dry, cold periods (for example the 
harmattan season in West Africa); contact with trade or nomadic animals 
through shared grazing, water and/or housing; a change in husbandry 
(e.g. towards increased intensification) and trading practices(FAO, 1999). 
As in rinderpest (RP), there is no known carrier state. Infected animals 
may transmit the disease during the incubation period (Lefevre and 
Diallo, 1990). 
1.6. Clinical features  
When PPR occurs in an area for the first time, it is possible that 
acute high fever with extreme depression and death occur before any 
other typical signs have been seen. A more typical picture, however, is 
that of a fast-spreading syndrome in sheep and/or goats characterized by 
the sudden onset of depression, discharges from eyes, nose and mouth, 
abnormal breathing with coughing, diarrhoea and deaths. Both goats and 
sheep are susceptible to infection and may show disease, they are not 
always affected simultaneously. For example, in Africa PPR is seen most 
commonly in goats, while in western and south Asia sheep are usually the 
most noticeable victims. The disease can, however, strike both species 
with equally devastating consequences (FAO, 1999). Virus appears in 
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blood, excretions and secretions 1–2 days before clinical signs (FAO, 
1999).The clinical disease of PPR in sheep and goats resemble to the 
rinderpest in cattle. It usually appears in the acute form with an 
incubation period of 2-10 days. There is a sudden rise in body 
temperature up to 40-410C .The temperature usually remains high for 
about 5-8 days before slowly returning to normal, preceding recovery or 
dropping below normal before death (Roeder and Obi, 1999; Pawaiya et 
al., 2004).The animals become depressed, anorexic and develop a dry 
muzzle. Serous nasal discharge, which becomes progressively 
mucopurulent, can crust over and occlude nostrils. Purulent ocular 
discharge with congested conjunctiva can encrust cementing eye lids 
together. If the death does not ensue, persist for around 14 days. Within 4 
days of onset of fever, the gums become hyperaemic, and erosive lesions 
develop in the oral cavity with excessive salivation but not to point of 
drooling. These lesions may become necrotic. Inflammation of 
gastrointestinal tract leading to severe diarrhea, occasional with blood and 
mucus. Pneumonia, dyspnea ,coughing and  sneezing in an attempt to 
clear nose, abdominal breathing also occur, dehydration and emaciation 
followed by secondary latent infections may be activated and complicate 
the clinical features (EL Hag and Taylor,1984). 
Abortions were noted in pregnant females (EL Hag and Taylor, 1984). 
Mortality rate can be up to 100% in severe outbreaks (Abu-Elzein, 1990). 
Mortality is usually low in endemic areas, but when associated with other 
diseases such as capripox, it can approach 100 per cent (Kitching, 1988). 
 Death usually occurs after 5-10 days (Taylor, 1984; Saliki, 1998). 
1.7. Pathogenencsis 
PPR virus, like other morbilliviruses, is lymphotropic and epithelio 
tropic (Scott 1981). Consequently, it induced the most severe lesions in 
organ systems rich in lymphoid and epithelial tissues. The respiratory 
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route is likely portal of entry. After the entry of the virus through the 
respiratory tract system, it localizes first and replicates in pharyngeal and 
mandibular lymph nodes as well as tonsil. Viremia may develop 2-3 days 
after infection, and 1-2 days before the first clinical signs appears. 
Subsequently viremia results in dissemination of the virus to spleen, bone 
marrow and mucosa of the gastro-intestinal tract and respiratory system 
(Scott, 1981).  
1.8. Histopathology   
PPR virus causes epithelial necrosis of the mucosa of the 
elimentary and respiratory tracts marked by the presence of eosinophilic 
intracytoplasmic and intranuclear inclusion bodies. Multinucleated giant 
cell (syncytia) can be observed in all affected epithelia as well as in the 
lymph nodes (Brown et al., 1991). In the spleen, tonsil and lymph nodes, 
the virus causes necrosis of lymphocytes evidenced by pyknotic nuclei 
and karyorrhexis (Rowland et al., 1971). Brown et al. (1991) using 
immunohistochemical methods detected viral antigen in cytoplasm and 
nuclei of trachea, bronchial and bronchio-epithelial cell, type II 
pneumocytes, syncytial cell and alveolar macrophages.  
1.9. The gross lesions 
The most characteristic lesions are usually seen in the digestive and 
respiratory system, but can be seen in the other system. In the digestive 
system inflammatory and necrotic lesions are seen in mouth and 
gastrointestinal tract and erosive stomatitis involving the inside of lower 
lip and adjacent gum. In severe cases, lesion may also be found on hard 
palate, pharynx, and upper third of esophagus. Rumen, reticulum, and 
omasum rarely have lesions. Sometimes, there may be erosions on pillars 
of rumen. The abomasum is a common site of regular outlined erosions 
and often oozes blood. In small intestine, lesions usually moderate. 
Extensive necrosis of payer,s patch, results in severe ulceration (Saliki, 
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1998). In the Large intestine, the iliocecal valve was congested together 
with the folds of the rectal and ceacal mucosa (El  Hag and Taylor, 1984). 
Zebra stripes (discontinuous streaks of congestion) in posterior part of 
colon and rectum and crests of mucosal folds. In the respiratory system 
small erosions and petechiae are visible on nasal mucosa, turbinate. 
Larynx and trachea. Broncho-pneumonia may be present, usually 
confined to the outer ovental areas and characterized by consolidation and 
atelectasi. There are pleuritis, which may become exudative and results in 
hydrothorax (EL Hag and Taylor, 1984). 
The spleen may be slightly enlarged and congested. Most of the lymph 
nodes throughout the body are engorged   and edematous (Saliki, 1998; 
El Hag and Taylor, 1984). Vulvovaginitis lesions similar to the lesions in 
the oral mucocutaneous junction may be present (Saliki, 1998). 
1.10.   Diagnosis 
1.10.1 Field diagnosis 
In the field, a presumptive diagnosis can be made on the basis of 
the clinical, pathological and by epizootiological findings. Laboratory 
confirmation is an absolute requirement particularly in areas or countries 
where PPR has not previously been reported (Taylor et al., 1979; Lefevre 
et al., 1990). 
1.10.2. Laboratory diagnosis 
According to Saliki et al (1994), a wide range of laboratory 
procedures have been described for detecting the virus such as, viral 
antigen, viral nucleic acid, and as antibodies.  
1.10.2.1. Specimens for laboratory diagnosis  
For the laboratory diagnosis specimens to be submit included blood 
in EDTA anticoagulant, clotted blood or serum (if possible paired sera), 
mesenteric lymph nodes, spleen, lung, tonsils and section of the ileum 
and large intestine. Swabs of serous nasal and lachrymal discharge may 
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also be useful. All samples should be shipped fresh (not frozen) on ice 
within 12 hours after collection (Saliki, 1998; El Hag and Taylor, 1984). 
The above sample should be collected in the acute phase of the disease, 
when clinical signs are readily apparent. Ideally, samples should be 
collected from several animals during an outbreak. Epidemiologic and 
clinical details should be provided with the samples, and each sample 
bottle should be marked carefully with an indelible pen. Details of each 
sample’s origin should be recorded for submission to the laboratory 
(Taylor et al., 2002). 
1.11. Serological test for detection of PPR antigens 
1.11.1. Immunocapture enzyme–linked immunosorbent assay 
(ELISA) 
The immunocapture enzyme-linked immunosorbent assay 
(ELISA), using several anti-N monoclonal antibodies (MAb), allows a 
rapid differential identification of PPR or rinderpest viruses ,and this is of 
great importance as the two diseases have a similar geographical 
distribution and may affect the same animal species. The test is very 
specific and sensitive it can detect 100.6TCID50/well (50% tissue culture 
infective dose) for the PPR virus. The results are obtained in 2 hours 
(Libeau et al., 1995).  
1.11.2. Counterimmunoelectrophoresis (CIEP) 
Counter immunoelectrophoresis (CIEP) is the most rapid test for 
detecting viral antigen. It is carried out on a horizontal surface using a 
suitable electrophoresis bath, which consists of two compartments 
connected through a bridge .The apparatus is connected to a high–voltage 
source. Agar or agrose (1-2%, [w/v]) dissolved in 0.025 M barbitone 
acetate buffer is dispensed onto microscope slides in 3 ml volumes and 
from six to nine pairs of wells are punched in the solidified agar. The 
electrophoresis bath is filled with 0.1M barbitone acetate buffer. The 
 16
pairs of wells in the agar are filled with the reactants. Sera in the anode 
wells and antigen in the cathode wells. The slide is placed on the 
connecting bridge and the ends are connected to the buffer in the troughs 
by wetted porous paper. The apparatus is covered, and a current of 10-12 
milliamps per slide is applied for 30-60 minutes. The current is switched 
off and the slides are viewed by intense light: the presence of 1-3 
precipitation lines between pairs of wells is a positive reaction. There 
should be no reactions between wells containing the negative controls 
(Durojaiye, 1984; Majiyagbe et al., 1984). 
1.11.3. Agar gel immunodiffusion (AGID) test 
It is a very simple and inexpensive test that can be performed in 
any laboratory and even in the field. Standard PPR viral antigen is 
prepared from mesenteric or bronchial lymph nodes, spleen or lung 
material and ground up as 1/3suspensions in buffered saline. These are 
centrifuged at 500g for 10-20 minutes, and the supernatant fluids are 
stored in aliquots at −20 oC. They may be retained for 1-3 years. Control 
antigen is prepared similarly from normal tissue. Standard antiserum is 
made by hyperimmunising sheep with 5ml of PPR virus with a titer of 
104TCID50 (50% tissue culture infective dose) per ml given at weekly 
intervals for 4 weeks. The animals are bled 5-7 days after the last 
injection. Standard rinderpest hyperimmune antiserum is also effective in 
detecting PPR antigen and gives results within 1 day but not sensitive to 
mild forms of PPR. (Durojaiye, 1982). 
1.11.4. Virus neutralization test  
Prescribed test for international trade, the test is highly sensitive and 
specific than other serologic test, but can be time consuming. The 
standard neutralization test is carried out in roller–tube cultures of 
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primary lamb kidney cell, or Vero cell when primary cells are not 
available (Taylor, 1979).   
1.12. Routine serological tests 
Goats and sheep infected with PPR virus develop antibodies that 
may be demonstrated to support a diagnosis by the antigen–detection 
tests. Tests that are routinely used are the virus neutralization (NT) test 
and the competitive ELISA. Other test, such as counter immuno 
electrophoresis (CIEP), agar gel immune diffusion (AGID), 
precepitinogen inhibition test, and indirect fluorescent antibody test have 
remain of little interest compared with the (NT) and ELISA (Durojaiye et 
al., 1983). 
1.13. Molecular diagnosis 
1.13.1. Nucleic acid recognition methods 
CDNA 32p labeled clones have been used to differentiate PPR and 
rinderpest but their use in routine diagnosis of PPR is not recommended 
due to short half-life of the 32P and the need for special equipment to 
protect the users (Diallo et al., 1988). 
1.13.2. Polymerase chain reaction PCR  
A PCR technique based on the amplification of the N protein and F 
protein genes have been developed for the specific diagnosis of PPR. This 
technique is very sensitive compared with other tests and results are 
obtained in 5 hours, including the RNA extraction (Forsyth et al., 1995). 
1.14. Virus isolation 
PPR virus may be isolated in primary lamb kidney or in African 
green monkey kidney (vero) cell culture. Monolayer cultures are 
inoculated with suspect material and examined daily for cytopathic effect 
(CPE). The CPE produced by PPR virus can develop within 5 days and 
consists of cell rounding and aggregation culminating in syncytia 
formation in lamb kidney cells. In vero cells sometimes difficult to see 
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the syncytia. Syncytia are recognized by a circular arrangement of nuclei 
giving a clock face appearance (Lefevre and Diallo, 1990; Durojaiye et 
al., 1983).    
1.15. Differential diagnosis 
Rinderpest with clinical sign is rare in goats and sheep in Africa. In 
India, these species are quite often involved in RP outbreaks. Clinically, 
RP and PPR are similar, but the former should be the prime suspect if 
disease involves both cattle and small ruminants. Confirmation requires 
virus isolation and cross-neutralization test. In addition to rinderpest, 
other condition that should be considered in differential diagnosis 
included pasteurellosis, contagious caprine pleurapneumonia, bluetongue, 
heart water, contagious ecthyma (contagious pustular dermatitis), foot 
and mouth disease, Nairobi sheep disease, coccidiosis, gastrointestinal 
helminthes infestations and plant or mineral poisoning (OIE, 2002). 
 1.16. Control 
1.16.1. Treatment  
There is no treatment for PPR. However, mortality rates may be 
decreased by the use of drugs that control the bacterial and parasitic 
complication. Specifically, oxytetracycline and chlortetracycline are 
recommended to prevent secondary pulmonary infection (OIE, 2000). 
1.16.2. Vaccination 
In the past, the rinderpest vaccine has been used to protect goats for 
at least 12 months against PPR. However, this practice is being phased 
out to avoid confusion during retrospective serologic studies. A 
homologous attenuated PPR vaccine is now available and gives strong 
immunity. There are also genetically engineered recombinant vaccines 
undergoing limited field trial (OIE, 2002). 
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1.16.3. Control and eradication  
Methods applied for rinderpest eradication may be appropriate for 
PPR and eradication is recommended when PPR appears in new area. 
These should include quarantine, combined with the use of focused 
(“ring”) vaccination and prophylactic immunization in high-risk 
populations. Until recently, the most practical vaccination against PPR 
made use of tissue culture rinderpest vaccine. Recently, a homologous 
PPR vaccine has been developed and the vaccine seed is available 
through the Pan African Veterinary Vaccine Centre (PANVAC). This 
vaccine of choice is becoming increasingly available. The vaccines can 
protect small ruminants against PPR for at least three years (FAO, 1999). 
Slaughter and proper disposal of carcasses and contact fomite, 
decontamination of facilities and equipment and restrictions on 
importation of sheep and goats from affected areas (Taylor, 1984; Diallo 
et al., 1988; lefevre, 1990). Awa et al. (2000) recommended that control 
program of vaccinating of small ruminants against PPR accompanied by 
strategic of antihelmintic treatment, should be considered.  
 1.17. Public   health  
There are no known health risks to humans working with PPR virus as no 
report of human infection with the virus exists (OIE, 2002). 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1. Preparation and sterilization of glassware 
Glassware: beakers, flasks, pipettes, cylinders, centrifuge tubes 
were boiled in water with a detergent for 20 minutes then rinsed in 
running water five times to remove the detergent completely. They were 
then immersed overnight in distilled water (DW), left to dry and then 
sterilized in hot air oven at 180 oC for 2 hours. 
2.2. Sera  
2.2.1. Serum samples 
A total of 400 serum samples were collected randomly from sheep 
and goats in different localities in Sudan in November 2007 as shown in 
Table 1. Animals were bled from the jugular vein, 5 ml of blood were 
collected from each animal and kept overnight at room temperature. Then 
serum was separated by centrifugation at 1500 rpm for 10 min. The 
separated sera were stored at –20 oC till examined. Samples from Blue 
Nile state were collected kindly by (Dr. Ibrahim, Daoud).   
2.2.2. . Hyperimmune serum (Positive control) 
Standard antiserum was raised in rabbits as described by Obi et al. 
(1990). PPR virus vaccine was injected subcutaneously 2 ml in the flank 
region .Subsequent three 2 ml injections were given intramuscularly at 2 
weeks interval. The blood was collected 7 days after last injection and the 
serum was separated and stored at −20 oC till used.  
 
2.2.3. New borne calf serum (sigma) (Negative control) 
New borne calf serum kindly supplied by Department of Viral 
Vaccines Production (CVRL) was used as a negative control. 
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2.3. Cell culture. 
African Green Monkey Kidney Cell (Vero cell), kindly supplied by 
Department of Viral Vaccines Production, CVRL, Soba was used. 
 2.3.1. Cell culture preparation 
 Confluent monolayer cell culture of Vero cell was used. The 
growth medium was removed and the cell briefly washed with sterile PD. 
Three ml of trypsin ─ versene solutions were added and the bottle 
incubated at 37 oC until cells flew freely when the bottle was tilted. Few 
drops of calf serum were added to stop the action of trypsin and versene 
and the suspension was centrifuged at 1000 rpm for 5 minutes. The 
supernatant was poured out and the cell pellet was resuspended in 10 ml 
of growth medium and mixed well by pipeting. The suspension was 
diluted in growth medium and distributed in tissue culture flasks or tubes 
and then incubated at 37 oC.   
  2.4. PPR Virus 
  PPR virus used in this study was obtained from the Central 
Veterinary Research lab, Soba, Sudan. It is a PPR virus vaccine strain 
[PPR 75/1] originally isolated in Nigeria in 1975 and attenuated in vero 
cell culture (Diallo et al, 1988).  
2.5. Serological tests 
2.5.1. Agar gel immunodiffusion test 
2.5.1.1. Preparation of agar 
The test was carried out as described in the Manual of Standards, 
Diagnostic Tests and Vaccines (OIE, 2002) as follows: 
Agarose (1%) in normal saline containing 0.125 g sodium azide as 
anticontaminent agent was dispensed into Petri dishes as 6ml /5cm dish. 
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Table 1: Serum samples collected from sheep and goats from different     
localities in Sudan for serological detection of PPRV antibodies. 
 
 
Serum samples collected from: 
                    
                           
 
Locality 
Goats   Sheep Total 
Khartoum  state 67         50     117 
El Gezera  state _          49 49 
Blue Nile state _          114 114 
River Nile state _          38 38 
El Ghadaref  state _          82 82 
Total 67         333   400 
 
 
− = No sample collected  
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2.5.1. 2. Preparation of PPR virus antigen 
PPR virus antigen was prepared as described by Taylor and Abequnde 
(1979). The PPRV (NIG.75/1) was grown in vero cell. At maximum 
cytopathic effect (CPE), the cell and the supernatant medium were 
harvested and clarified at 2000 rpm for 10 min. The cell deposit was then 
washed with cold PBS, recentrifuged at the above speed and the 
supernatant was discarded. The cell, deposit was resuspended in 1/250 
original volume in cold PBS and then subjected to three alternate cycles 
of freezing and thawing, followed by centrifugation at 2000 rpm for 10 
min. The supernatant was then collected and stored at –20oC and was 
used as a positive PPRV antigen.  
2.5.1.3. Test procedure 
       Wells were punched in the agar following a hexagonal pattern 
with central well. The wells were 5 mm in diameter and 5 mm apart. The 
central well was filled with positive control Ag and three peripheral well 
with positive antiserum and one well with negative antiserum and the 
remaining peripheral wells were filled with test sera a total of 400 serum 
samples collected from sheep and goats (2.1.1) were examined.  Lines 
when developed between the serum and positive antigen within 18–24  
hours were intensified by washing the agar with 5% glacial acetic acid for 
5 minutes. Positive serum reactions showed lines of the same identity as 
the positive control serum. This procedure was also carried out with all 
apparently negative tests before recording a negative result. Another 
arrangement was done by filled the central well with control Ag and 
peripheral well with test sera and one well with hyperimmune serum fig 
(1).  
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2.5.2. Serum Neutralization test (SNT) 
A total of 400 serum samples collected from sheep and goats 
(2.1.1) were tested. Before testing the sera were inactivated at 56 oC for 
30 min. 
 
2.5.2.1. Test procedure 
The test was conduced as described by Taylor (1979). One ml of 
inactivated serum was mixed with equal volume of stock virus suspension 
containing approximately 103TCID50/ml. Then the serum –virus mixture 
was held at 37 oC for 2 h.  
The serum–virus mixture (0.2) ml was inoculated into 3 wells of tissue 
culture plate of 24 wells, followed immediately by the addition of 1.0 ml 
of growth medium containing 105 of freshly suspended cell into each 
well. 
Then the plate was incubated at 37Co and were examined for cytopathic 
effect (CPE) on days 5, 8, 11 and finally on day 13.  
When the test was terminated complete protection of (CPE) even one out 
of the 3 wells per serum sample was interpreted as an evidence of 
neutralizing antibodies.  
2.5.3. Competitive   ELISA 
2.5.3.1. Principle of the test 
It is an assay to determine the presence of anti–PPRV antibody in 
serum. It is based on the competition between the anti-PPRV monoclonal 
antibody and the antibodies in the serum sample binding to the PPRV 
antigen. The presence of antibodies to PPRV in the serum sample will 
block reactivity of the monoclonal antibody resulting in reduction in 
expected color following the addition of conjugate and 
substrate\chromogen solution. As this is a solid phase assay, wash step 
are required between each step to ensure removal of unbounded reagents. 
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Competitive ELISA kit used was that of Biological Diagnostic Supplied 
LTD (BDSL), Flow Laboratories and Institute for Animal Health. For use 
in seromonitoring and surveillance of cattle, sheep and goats for PARC, 
WAREC and SAREC. Pirbright, Surrey, England. Product and the 
technique described sheet fact accompanied the kit was followed. 
 
2.5.3.2. Antigen 
  PPRV antigen: One m1 of sterile distilled water supplied with the 
kit, was added to the freeze-dried contents of the vial and mixed till 
completely dissolved and stored at –20°C till used. 
2.5.3.3. Control sera 
Strong positive (++c), week positive (+c), negative (-c): one  ml of 
sterile distilled water supplied with the kit, was added to the freeze-dried 
contents of the each vial and mixed well until dissolved and stored at –
20° C till used. 
2.5.3.4. Monoclonal antibody (MAb) 
One ml of sterile distilled water supplied with the kit, was added to 
the freeze-dried contents of the vial and mixed till completely dissolved 
and stored at –20°C till used. 
2.5.3.5. Anti species conjugate 
One vial contents of monoclonal (Mouse anti–PPR monoclonal 
antibody) was dissolved in 1ml of sterile distilled water supplied with the 
kit.  
2.5.4. Reagents  
2.5.4.1. Coating buffer (phosphate buffer saline (PBS)) 
Phosphate buffered saline (PBS, pH 7.4): was prepared by 
dissolving content of one liter PBS pouch in 100 ml of fresh glass 
distilled water to make 10X PBS. The stock was diluted 1 in 10 
depending on requirements and stored at 4°C. 
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2.5.4.2. Washing buffer (WB) 
Washing buffer was prepared by mixing 200 ml of PBS with 800 
ml of DDW, and pH was adjusted to 7.4 ± 0.2. 
 
 
2.5.4.3. Blocking buffer (BB)  
Blocking buffer containing 0.1% Tween-20 and 0.2% negative 
serum. It was prepared fresh every time when needed.  
2.5.4.4. Chromogen-substrate solution 
One tablet (30 mg) of chromogen; Orth-phenylenediamine (OPD) 
was dissolved in75.0 ml fresh glass distilled water and stored at –20°C till 
used. H2O2 solution (3%) was added just before use at the rate of 4.0 µl 
H2O2 per ml of OPD solution. 
2.5.5. Test procedure 
The test was carried out according to the manufacture instructions 
as follows:  
Fifty µl of an antigen diluted (1\100) with PBS were dispensed to all 
wells of an ELISA micro plate. The plate was covered and placed on a 
shaker for one hour, then incubated overnight at +4oC. 
 After 3 wash cycles with washing buffer, 40 µl of blocking buffer were 
dispensed to all 96 wells of the plate. 
According to the plate layout (Figure, 5), 10 µl from test and control sera 
(++c, +c, -c) and monoclonal sera were added to appropriate wells. 
 Ten µl of blocking buffer were added to the monoclonal antibody control 
wells and 60 µl of blocking buffer to the conjugate control wells.  
Fifty µl of MAb (1\100 BB) were added to all wells except the conjugate 
control wells. Then the plate was covered and incubated at 37oC on a 
shaker for one hour. 
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Then the plate washed vigorously 3 times with washing buffer and dried. 
Then 50µl of conjugate (1\1000 BB) were dispensed to all wells of the 
plate, then covered and incubated at 37oC on shaker for one hour. 
The plate was washed 3 times with washing buffer and dried.  
Fifty µl of substrate\chromogen were dispensed to all wells. 
Other clean micro titer plate was used for blanking. Fifty µl 
substrate\chromogen solutions were added to the row of blanking plate 
and incubated for 10 min in the dark. 
The reaction was stopped by addition of 50µl stop solution (H2SO4) to all 
wells of the test plate and the row of the blanking. 
 Plates were read in a micro plate reader( BDSL) Immunoscan. MS serial 
No RS-232C at 492 nm filter. The reader was connected to a computer 
loaded with ELISA Data Interchange (EDI) software, which was used to 
automate the reading and calculation of percentage of inhibition (PI) 
values. The optical density (OD) values were converted to percentage 
inhibition by using the following formula: PI=100-(absorbance of the test 
wells/absorbance of the MAb control wells) X100. Sera showing PI 
greater than 50% were considered positive. 
 2.6. Data analysis  
2.6.1. Principle of parameters  
 
 Condition Present Condition Absent 
Test positive True Positive False Positive 
Test negative False Negative True Negative 
 
The sensitivity (Sn) is defined as the probability that the test is positive 
when given to a group of patients who have the disease. It is calculated 
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by the formula Sn = (TP\ (TP+FN)) X 100. It is expressed as percentage 
(Munro, 2005). 
The specificity (Sp) of a screening test is defined as the probability that 
the test will be negative among patients who do not have the disease. It is 
calculated by the formula Sp = (TN\ (TN+FP)) X 100 (Munro, 2005). 
The positive predictive value (PPV) of a test is the probability that a 
patient who tested positive for the disease actually have the disease. It is 
calculated by the formula PPV = (TP\ (TP+FP)) X 100 (Munro, 2005). 
The negative predictive value (NPV) of a test is the probability that a 
patient who tested negative for the disease will not have the disease. It is 
calculated by the formula NPV = (TN\ (TN+FN)) X 100 (Munro, 2005). 
The efficiency (EFF) of a test is the probability that the test result and the 
diagnosis agree. It is calculated by the formula EFF = ((TP+TN) \ 
(TP+TN+FP+FN)) X 100 (Munro, 2005). 
2.6.2. Statistical analysis  
The sensitivity (Sn), specificity (Sp), positive predictive value (PPV), 
negative predictive value (NPV) and the efficiency (EFF) of the AGID 
and NT test were determined in relation to ELISA as described by Munro 
(2005) and SPSS software (Statistical Package for Social Sciences) 
version 11.5, was used for statistical analysis of data.  
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Figure 1:  The different arrangements of Ag and hyperimmune serum 
and serum samples in agar gel immundiffusion test 
HS: Hyperimmune serum   
Ag: Antigen 
 S: Serum sample 
 
 
 
 
 
 
 
Ag 
S 
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HS 
S 
S 
S 
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 1 2 3 4 5 6 7 8 9 10 11 12 
A Cc Cc 1 5         
B ++c ++c 1 5         
C ++c ++c 2 6         
D +c +c 2 6         
E +c +c 3          
F cm cm 3          
G Cm cm 4         40 
H C- c- 4         40 
 
 Figure 2: ELISA Plate layout         
Cc: conjugate control, ++C: strong positive control, +C weak positive 
control, Cm: monoclonal antibody control, C- : negative control. 
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CHAPTER THREE 
RESULTS 
Four hundred serum samples collected from sheep and goats in 
different localities in Sudan as shown in Table 1 were examined by 
different serological method for screening PPR virus antibodies.  
3.1. Examination of the sera by agar gel immunodiffusion (AGID) 
test 
Out of 400 sheep and goats serum samples tested by AGID test, 
103 were found positive (25.8%) for PPR antibodies .The detection of the 
PPRV antibodies in different localities by AGID test is shown in Table 2.     
3.2. Examination of the sera by neutralization test (SNT) 
Out of 400 sheep and goats serum samples tested by SNT, 167   
were found positive (41.8%) for PPR antibodies the detection of the 
PPRV antibodies in different localities by SNT is shown in Table 2.                   
3.3. Examination of the sera by cELISA test 
Out of 266 sheep and goats serum samples tested by cELISA test, 
138 samples were found positive (51.9%) for PPR antibodies. The 
detection of the PPRV antibodies in different localities by c ELISA test is 
shown in Table 3. 
3.4. Comparison between cELISA, SNT and AGID tests 
The detection of PPRV antibodies in a total of 266 serum samples 
examined by AGID, SNT and cELISA were compared. cELISA test 
detected the highest percentage (51.9%) of seropositive while SNT and 
AGID test detected 41.8% and 25.8% seropositive respectively. 
The percentage of seropositive sample detected by the three serological 
tests in each locality is shown in Table 4 and Figure 3. ELISA test 
detected higher seropositive samples (51.9%) when compared to AGID 
test (25.8%) and SNT (41.8%). The AGID test agrees with ELISA in 
detection of 62 seropositive and 123 seronegative samples (Table, 5), 
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while SNT agrees with ELISA in detection of 95 seropositive and 115 
seronegative samples (Table, 6). 
The statically analysis showed SNT had higher sensitivity than AGID 
(68.8% Vs 44.9%), but lower specificity than AGID (89.8% Vs 96.1%) in 
relation to ELISA (Table, 7).  
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Table 2: Detection of PPRV antibodies in 400 serum samples 
collected from sheep and goats in different localities by AGID test 
and virus neutralization test (SNT). 
 
 
 
 
 
 
 
 
 
Locality 
 
 
Samples 
examined 
 
AGID 
 Positive 
 
SNT 
Positive 
Khartoum 
state 
  67   sheep 
  50   goats 
15 (22.4%) 
21 (42%) 
25 (37.3%) 
34 (68%) 
El Gezera 
state 
  49   sheep 12 (24.5%) 
 
24(49%) 
Blue Nile 
state 
   114    sheep 29 (25.4%) 43 (37.8%) 
River Nile 
state 
    38    sheep 2 (5.3%) 5 (13.2%) 
El Ghadaref 
state 
   82    sheep 24 (29.3%) 36 (43.9%) 
Total        400        103(25.8%)    167(41.8%) 
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Table 3: Detection of PPRV antibodies in 266 serum samples 
collected from sheep and goats in different localities by cELISA test. 
 
Goats Sheep 
Locality 
Samples 
Examined 
Samples 
positive (%) 
Samples 
Examined 
Samples 
positive (%) 
Khartoum state 
El Gezera state  
Blue Nile state 
River Nile state 
El Ghadaref state  
36 
        _ 
_ 
_ 
_ 
22 (61.2 %) 
_ 
_ 
_ 
_ 
47 
30 
75 
22 
56 
 4 (8.5%) 
 11 (36.7%) 
   41 (54.7%) 
 8 (36.4%) 
    16 (28.6%) 
Total 36   22 (61.1 %) 230   116 (50.4%) 
 
− = No sample collected and examined  
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Table 4: PPRV seropositive serum samples collected from goats and 
sheep in different localities in Sudan detected by AGID, SNT and 
cELISA tests (n=266). 
 
 
 
 
 
 
 
 
Locality 
 
 
No. of 
Sample 
 
AGID 
 Positive 
 
SNT 
Positive 
 
cELISA      
Positive 
Khartoum 
state 
  47  sheep 
  36    goats 
12 (25.5%) 
10 (27.8%) 
32 (68.0%) 
12 (33.3%) 
40 (85.1%) 
22 (61.1%) 
El Gezera 
state 
  30   sheep 6 (20%) 10   (33.3%) 11   (36.7%) 
Blue Nile 
state 
   75    sheep 22 (29.3%) 32 (42.6%) 41 (54.6%) 
River Nile 
state 
    22    sheep 3 (13.6%) 5 (22.7%) 8 (36.4%) 
El Ghadaref 
state 
   56    sheep 14 (25%) 17 (30.4%) 16 (28.6%) 
Total        266 67 (25.2%) 108 (40.6%) 138 (51.9%) 
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Table 5: PPRV antibodies detection by agar gel-immunodiffusion test 
in relation to cELISA test (n=266). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
cELISA  
Positive Negative 
 
Total 
Positive 62 5 67 
Negative 76 123 199 
 
AGID 
Total   138 128 266 
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Table 6: PPRV antibodies detection by neutralization test in relation 
to cELISA test (n=266) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
cELISA  
Positive Negative 
 
Total 
Positive 95 13 108 
Negative 43 115 158 
 
SNT 
Total 138 128 266 
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Table 7: The Sensitivity, specificity, positive predictive value, 
negative predictive value and efficiency of AGID and SNT tests in  
relation to cELISA test (n=266). 
 
Test Parameter 
AGID SNT 
Sensitivity 44.9% 68.8% 
Specificity 96.1% 89.8% 
Positive predictive value 92.5% 88.0% 
Negative predictive value 69.6% 72.8% 
Efficiency 69.6% 79.0% 
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Figure 3: Frequency of seropositive and seronegative PPRV 
antibodies detected by AGID test, SNT and cELISA test in serum 
samples of sheep and goats (n=266).  
 
 
 
 
 
 
 
 
 
CHAPTER FOUR 
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DISCUSSION 
Peste des petits ruminants (PPR) is an acute viral disease .The 
disease mainly affects sheep and goats, however, goats are affected more 
often and more severely than sheep (Singh et al., 2000). The disease is 
highly contagious and causes varying degree of morbidity and mortality 
in susceptible population (Radostits et al., 2000). 
In Sudan, PPR was first reported by El Hag et al. (1984) .Within a 
decade, PPR became endemic in the country, imposing severe threat to 
small ruminants resulting in heavy economic loss to the farmers as well 
as small ruminant industry. 
The present study assessed the seropositivity to PPR virus antibodies in 
sheep and goats. A total of 400 serum samples from sheep and goats were 
collected from different localities in Sudan and were screened for PPR 
specific antibodies by SNT, AGID and cELISA. The overall PPRV 
antibodies seroprevalence recorded in sheep and goats was 41.8%, 
25.8%, and 51.9% by SNT, AGID and cELISA respectively. 
Three methods may be used to diagnose and monitor the distribution and 
prevalence of PPR: Case recording of PPR outbreaks, serological 
detection of PPR specific antibodies and detection of the virus. Although, 
case recording of PPR outbreaks could give some clues in the areas where 
the disease is endemic, serological tests for monitoring the antibodies 
against PPRV must be both highly specific and sensitive to provide 
accurate results in field studies. Further, a diagnostic test to be used for 
serological surveys must be rapid and economic. However, laboratory 
diagnosis is essential for confirmation by detection of virus. 
Conventional serological tests such as AGID and Counter 
immunoelectrophoresis (CIEP) have been used in the past for diagnosis 
of rinderpest but they often fail in specific diagnosis of PPR due to cross 
reaction between PPRV and RPV. Thus, monoclonal antibody based 
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cELISA developed by Anderson and McKay (1994) became the most 
popular test for diagnosis of PPR, as it was highly sensitive and specific. 
Although, the assay was highly specific and sensitive, mere detection of 
antibodies could not confirm the presence of virus at the locations where 
specific vaccination against the PPRV was practiced (Saliki et al., 1994). 
 AGID test is known to be reliable for detection of specific antibodies in 
species where there is no available commercial conjugate to their 
antibodies (Taylor, 1990; OIE, 2000). 
In the present study AGID test detected PPR virus antibodies in 103 
samples out of 400 sera sample (25.8%) collected from different localities 
in Sudan (Table, 1), in this study. Durojaiye and Taylor (1984) described 
AGIDT to monitor the appearance of antibody in experimentally infected 
sheep and goats. Virus neutralization test of serum samples collected 
from sheep and goats could detect the presence PPRV antibody (Saliki et 
al., 1993; Anderson et al., 1991). Out of 400 samples screened from 
different localities in Sudan (Table, 1),SNT detected PPRV antibodies in 
167 samples (41.8%). This is in agreement with the observations of 
Taylor. (1979); Libeau et al. (1995) and Singh et al. (2004).They were 
able to detect PPRV antibodies by VNT in field and laboratory serum 
samples. Durojaiye and Taylor found, of the 137 convalescent field serum 
samples, 80 were positive to AGID test and 78 to the neutralization test, 
71 were positive to both the tests. However, in this investigation NT 
detected higher prevalence of PPRV (41.8%) than AGID test (25.8%). 
In this investigation study significant PPRV antibodies were detected in 
serum samples of sheep and goats screened by cELISA. Of the 266 serum 
samples, 138 samples were seropositive to PPR (51.9%). Libeau et al, 
(1995) and Singh et al, (2004) reported 24 out of 271field serum  
samples and 691 out of 1700 field and laboratory serum samples were 
positive. 
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cELISA test is described as diagnostic technique, which is simple, rapid, 
specific and sensitive, test for screening of antibodies to various 
morbilliviruses (Saliki et al., 1993; Libeau et al., 1995). This test is 
having several advantages over NT, as it does not require cell culture 
facility and strict sterility of serum samples. Rapid diagnosis and 
screening of large number of sera sample is therefore, possible using the 
cELISA. Morbillivirus cELISA detected anti-RPV, and anti-PPRV 
antibodies, in all the reference RPV and PPRV antisera containing VN 
titers 1:8, suggesting that the assay could simultaneously detect 
antibodies against RPV and PPRV (Choi et al., 2004). The test used 
monoclonal antibody to neutralize epitope of hemagglutinin protein (H-
protein) of the virus, revealed presence of PPR virus specific antibodies 
of PPR without showing cross-reaction with antibodies of RP (Kulkarni 
et al., 1996; Choi et al., 2004). 
Efficacy of cELISA compared very well with SNT, having high relative 
specificity (98.4%) and sensitivity (92.4%). The sensitivity of c-ELISA 
for PPR sero-surveillance was more (95.4%), if the target population was 
non-vaccinated, and it had been employed for detection of PPR 
circulating antibodies (Anderson et al., 2000). 
It was opined that the cELISA developed could easily replace SNT for 
sero-surveillance, seromonitoring, diagnosis from paired sera samples 
and end-point titration of PPR virus antibodies (Singh et al., 2004). In 
India epidemiological scenario, suggested that cELISA kit could prove to 
be an important tool for sero-monitoring and serosurveillance of PPRV 
antibodies (Sreenivasa et al., 2002).In previous study it was observed that 
the test can detect low levels of antibodies in newborn sera containing 
maternal antibodies. Thus the test may be useful tool for standardization 
and accurate determination of immune status (Libeau et al., 1995). 
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Also, the present study revealed cELISA is more sensitive test when 
compared to AGID test and SNT as cELISA detected more PPRV 
antibodies positive samples (51.9%) than AGID test (25.8%) and SNT 
(41.8%). 
Since previous studies proved cELISA is efficient diagnostic technique 
which is specific and sensitive for detection of PPRV antibodies and also 
this study revealed cELISA is more sensitive than the other two tests, it 
was decided to examine the sensitivity and specificity of AGID test and 
SNT in relation to cELISA. 
The statistical analysis showed NT had higher sensitivity than AGID test 
(68.8%Vs 44.9%), but lower specificity (89.8%Vs 96.1%), in relation to c 
ELISA. This indicates NT is second test of choice if facilities are equally 
available.      
In Sudan, prevalence of PPR disease was screened by cELISA (Intisar, 
2002). She detected PPRV antibodies in 75.7% serum samples collected 
from nonvaccinated sheep and goats. This study confirms the previous 
findings (Intisar, 2002 ) as it detected PPRV antibodies (51.9%) in serum 
samples of sheep and goats with no vaccination history .This indicates the 
exposure of sheep and goats to this virus and the disease remains 
prevalent in the country.   
 
 
 
 
 
 
 
 
Conclusions and Recommendation 
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Conclusions 
From the finding of this study, it can be concluded that:  
– PPRV antibodies were detected in serum samples collected from sheep 
and goats in non vaccinated sheep and goats by AGID (25.8%), SNT 
(41.8%) and cELISA (51.9%).  
– The detection of PPRV antibodies indicates the exposure of the sheep 
and goats to PPRV and the disease remains prevalent in the Sudan.   
– Competitive ELISA test detected the highest PPR seropositive.  
 – The statistical analysis revealed the SNT is second test of choice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recommendation 
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From the results and discussion it can be recommended that: 
1. Serosurveillance of PPR in small ruminants in all states of Sudan. 
2. Serosurveillance of PPR in wild ruminants and other domestic 
ruminants to investigate the possible role of the wild life and 
domestic ruminants in the cycle of PPR. 
3. Strategies for the control of PPR need to account for the dynamics 
of sheep and goats population. 
4. Mass vaccination in endemic area, and along the routes of animal 
movement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     REFERENCES               
 46
 
Abu-Elzein, E.M.E.; Hassanien, M.M.; Al-Afaleq, A.I.; Abd-Elhadi, M.A. 
and Housawi, F.M.I. (1990). Isolation of peste des petits ruminants from 
goats in Saudi Arabia. Vet. Rec., 127(12): 309–310. 
 
Ali, Abu Obieda. Ali. Osman(2006). Laboratory Diagnosis of a 
Moribillivirus Infection of camels in Eastern Sudan. . M. V. Sc. thesis 
Khartoum: University of Khartoum.    
 
Anderson, E. C.;   Jago ,  M .; Mlengeya, T. ; Timms,  C.; Payne, A. and 
Hirji,K. (1990). A serological survey of rinderpest antibody in wildlife 
and sheep and goats in northern Tanzania. Epidemiol. Infect., 105:203-
214. 
Anderson; McKay, J. A; and Butcher, R.N.(1991).The use of monoclonal 
antibodies in competitive ELISA for the detection of rinderpest and peste 
des petits ruminants viruses .The seromnitoring of rinderpest throughout 
Africa .Phase one Proceedings of Final Research Co-ordination Meeting 
of the FAO-IAEA-SIDA-OAU-IBAR-PARC. Research Programmers 
held in Bingerville. Cote d, voire.19-23 November 1990. 
 
Anderson, J; and McKay,J.A. (1994). The detection of antibodies against 
peste des petits ruminants virus in cattle, sheep and goats and the possible 
implication to rinderpest control programmes. Epidemiology and 
Infection. 112(1):225-231. 
   
Anderson, J. (1999).Collection and submission of diagnostic specimens to     
the FAO World Reference Laboratory for Rinderpest. Manual of FAO 
World Reference Laboratory for Rinderpest. Institute for Animal Health 
,Pibiright  Laboratory ,Surrey,UK. 
 
Anderson,J.;Lefevre,P.C.; Wafula,.J.S.; and Wamwayi,H.M.(2000).Peste des 
ptits ruminants In :Manual of standards for diagnostic tests and vaccine, 
Office International des Epizootic (OIE).Edited by the OIE standards 
commission and adopted by the International Committee of the OIE 4th 
edition .Publ. Paris, France .pp 77-81. 
 
 47
Appel ,M.J.G.;P., Gibbs ;E.P.J ., Martin ;S .J ., Termeulen ; V., Rima  ; 
B.Kstephenson ,J .R and Taylor , W .P (1981). Morbillivirus diseases of 
animals and man. in Kurstak and C. Kurstak.. In: Comparative Diagnosis 
of viral Diseases IV Vertebrate Animal and Related Viruses Part B-RNA 
viruses.  New York: Acad .press., pp .235-297. 
 
Awa, D.N.; Njoya, A. and Ngo Tama, A.C. (2000). Economics of 
prophylaxis against peste des petits ruminants and gastrointestinal 
helminthosis in small ruminants in north Cameroon. Tropical Animal 
      Health and Production, 32(6), 391-403. 
 
 
Awad El Karim,M.H.;Ali, Y.O.; Hajir,B.S.; Fayza,A.O.and Hadia,J.A.(1994). 
Observation on epidemiology of peste des petits ruminant in Sudan .The 
Sudan Journal for Veterinary Research, 13:29-34. 
 
Barrett, T.; Romero, C.H.; Baron, M.D.; Yamanouchi, K.; Diallo, A.; 
Bostock, C.J. and Black, B.(1993).The molecular biology of rinderpest 
and peste des petits ruminants. Ann. Med. Vet., 137 (2): 77-85. 
 
Brown, C.C.;Mariner,J.C.; and Olander,H.J.(1991). An immunohistochemical 
study of the pneumonia caused by PPR virus. Vet.Path., 28:166-170. 
 
Chip,S.,(1993).An economic analysis of the prevention of peste des petits 
ruminants in Nigerien goats. Preventive Veterinary Medicine.16 (2): 141-
150. 
 
Choi, K.S.; Nah, J.J.; Choi, C.U.; Ko, Y.J.; Sohn, H.J.; Libeau, G.; Kang, 
S.Y. and Joo, Y.S. (2004).Monoclonal antibody-based competitive 
ELISA for simultaneous detection of rinderpest virus and peste des petits 
ruminants virus antibodies. Vet. Microbiol., 96 (1):1-16. 
 
Couacy-Hymann, E.R.F.; Bidjeh, K.; Angba, A.; Domenech, J. and Diallo, A. 
(1995). Protection of goats against rinderpest by vaccination with 
attenuated peste des petits ruminants virus. Res. Vet. Sci., 59: 106-109. 
 
 48
Dhar, P.; Sreenivasa, B.P.; Barrett, T.; Singh, R.P. and  Bandyopadhyay, S.K. 
(2002). Recent epidemiology of peste des petits ruminants virus (PPRV). 
Vet. Microbiol., 8:153–159. 
 
Diallo, A. (1990). Morbillivirus group: Genome organization and proteins. 
Vet. Microbiol., 23:155-163. 
 
Diallo, A. (2002). Rapid and sensitive detection of peste des petits ruminants 
virus by a polymerase chain reaction assay. J. Virol. Methods., 100: 17–
25. 
 
 
Diallo, A.; Barrett, T.; Barbron, M. ; Shaila, M.S. and  Taylor, W.P. (1988). 
Differentiation of rinderpest and peste des petits ruminants viruses using 
specific cDNA clones. J. Virol. Methods., 23: 127–136. 
 
Diallo, A.; Libeau, G.; Couacy-Hymann, E. and Barbron, M. (1995). Recent 
developments in the diagnosis of rinderpest and peste des petits 
ruminants. Vet. Microbiol., 44 (2-4): 307-317. 
 
Durojaiye O .A.; Obi T.U. and Ojo O. (1983).Virological and serological  
diagnosis of peste des petits ruminants. Trop. Vet., 1 (1): 13-17. 
 
Durojaiye, O.A. (1982). Precipitating antibody in sera of goats naturally 
affected with peste des petits ruminants. Trop. Anim. Hlth. Prod., 14 (2): 
98-100. 
 
Durojaiye, O.A. and Taylor, W.P. (1984). Preliminary observations on plaque 
formation by the virus of peste des petits ruminants .Tropical-
Veterinarian, 2 (3): 148-150. 
 
Durojaiye, O.A. (1984). Detection of the antigen of peste des petits 
   ruminants virus in tissues by the indirect immuno-fluorescence 
technique. Niger. Vet. J., 13 (2), 77–80. 
 
Durojaiye, O. A.; Taylor, W.P. and Smale, C. (1985).The ultra structure of 
PPR virus. Zentrapltt fur Veterinarmedizin (B), 32(6):460-465. 
 49
 
El  amin, M.A.G.and Hassan, A.M. (1998). The seromonitoring of rinderpest 
throughout Africa, phase III results for 1998. IAEA, VINNA, Food and 
Agriculture Organization /International Atomic Energy Agency. 
 
El  Hag, B.A. and Taylor, W.P. (1984) .Isolation peste des petits ruminants 
from  sheep and goats in the Sudan. Research in Veterinary Science, 
36:1-4. 
 
El Hag, B.A. (1973). A natural outbreak of rinderpest involving sheep,                         
goats and cattle in Sudan. Bulletin of Epizootic Diseases of Africa, 
12:421-428 
 
FAO: Food and Agriculture World Organization (1999). Manual on 
procedures for disease eradication by stamping out.  
 
Fenner, Frank; Peter, A; Bachmann, E; Gibbs, Paul J; Frederick, A; Murphy; 
Studdert, Michael J.; White, David O. (1987) .Veterinary Virology, 2:30-
38. 
 
Frederick, A.; Murphy, F.A; Gibbs, Poul J.; Michael, J.; Studdert, Marian J. 
and Horzinek, M. (1999). Veterinary Virology, Third Edition, 26:411-
415. 
Forsyth , M.A. and Barrett, T. (1995). Evaluation of polymerase chain 
reaction for the detection and characterization of rinderpest and peste de 
petit ruminants viruses for epidemiological studies. Virus Res., 39: 151-
163. 
 
Gargdennec, L. and Lananne,A.  (1942).La peste des petits ruminants. 
Bulletin des services Zootechniques et des Epizootics de I’ Africa 
Accidental Francaise, 5:16-21. 
 
Gibbs,E.P.J.; Taylor W.P.; Lawman M.J.P. and Bryant, J. (1979). 
Classification of peste des petits ruminants virus as the fourth member of 
the genus Morbillivirus. Intervirology, 2: 268-274. 
 
 
 50
Govindarajan, R.; Koteeswaran, A.; Venugopalan, A.T.; Shyam, G.; 
Shaguna, S.; Shaila, M.S. and Ramachandran, S. (1997). Isolation of 
peste des petits ruminants virus from an outbreak in Indian buffalo 
(Bubalus bubalis). Vet. Rec., 141: 573–574. 
 
Hamdy,F.W.;Dardiri, A.H. and Nduaka, O. (1976).Etiology of stomatitis-
pneumoenteritis complex in Nigerian dwarf goats. Canadian Journal of 
Comparative Medicine, 40: 276-284. 
 
Hunt, Margaret .(2008) .Microbiology and immunology on –line University of 
south Carolina school of medicine RNA virus Replication strategies .4. 
 
Ikede, B.O. (1983).Histopathology of natural cases of PPR, characteristic 
lesions and changes occurring during the disease peste des petits 
ruminants( PPR) in sheep and goats .Proceeding of the International 
workshop held at IITA Ibadan ,Nigeria. 24-26 September. D.H. Hill 
(eds).ILCA,Addis Ababa. Ethiopia. 
 
Intisar, K. S. (2002). Studies on peste des petits ruminants in Sudan. M. V. 
Sc. thesis Khartoum: University of Khartoum.   
 
Isoun,T.T; and Mann, E.(1972).A stomatitis pneumoentritis complex of sheep 
in southern Nigeria. Bull. Epizootic. Dis . Afr, 20:167-174.   
   
Johnson, R.H.; and Ritchie, J. S.D. (1986). A virus associated with pseudo 
rinderpest in Nigerian dwarf goats. Bull. Epizootic. Dis. Afr., 16: 411–
417. 
 
Kitching, R.P. (1988). The economic significance and control of small 
ruminant viruses in north Africa and west Asia. In: Increasing small 
ruminant productivity in semi-arid areas, ICARDA. Thompson, F.S. (Ed.) 
pp 225-236. 
 
Kulkarni, D.D.; Bhikane, A.U.; Shaila, M.S.; Varalakshmi, P.; Apte, M.P. 
and Narladkar, B.W. (1996). Peste des petits ruminants in goats in India. 
Vet. Rec., 138 (8): 187-188. 
 
 51
Lefever, P .C. (1982). Peste des petits ruminants et infection bovipestique des 
ovins et caprins (Syntheses bibliographique). Institute d,Elevage  et de 
Medicine Veterinaries des pays  Tropicaux, 94704 Maisons-Alfort, 
France, pp 95. 
  
Lefevre, P.C.; and Diallo, A. (1990). Peste des petits ruminants. Rev 
.Sci.Tech. Off. Int. Epiz., 9:951-965. 
 
Libeau G.;Prehaud C.;Lancelot R.; Colas F.;Guerre L.;Bishop D.H.L. and 
Diallo A. (1995).Development of a competitive ELISA for detecting 
antibodies to the peste des petits ruminants virus using a recombinant 
nucleoprotein. Res.Vet. Sci., 58:50-55.  
 
 
Majiyagbe K.A.; Nawathe D.R. and Abegunde A.(1984). Rapid diagnosis of                         
PPR infection, application of immune-electrol-osmophoresis(IEOP) 
technique. Rev.Elev.Med.Vet.Pays Trop., 37: 11-15. 
 
Munro, Barbra (2005). Statistical method for health care research.5th edition, 
89-90. 
 
Murphy, F.A.; Gibbs, E.P.J.; Horzinek, M.C. and Studdert, M.J. (1999). 
Classification and nomenclature of viruses. In: Veterinary Virology, 3rd 
Edn, Academic press, New York. pp 413. 
 
Nanda, Y.P.; Chatterjee, A.K.; Purohit, A.; Diallo, A.; Innui, K.; Libeau, G.; 
Thevasagayam, J.A.; Bruning, A.; Kitching, R.P.; Anderson, J.; Barrett, 
T. and Taylor,W.P. (1996). The isolation of peste des petits ruminants 
virus from Northern India. Vet. Microbiol., 51 (3-4): 207-216. 
 
 Nawathe, D. R. (1984).The control of peste des petits ruminants in Nigeria. 
Prev. Vet .Med., 2:147-155. 
 
Ndauka,O; and Ihemelandu,U.C.(1973).Observations on pneumoentritis 
complex in dwarf goats in eastern states of Nigeria-Preliminary report, 
Bull. Epizootic. Dis. Afr., 21:87-98. 
 
 52
Nussieba, A. Osman (2005). Peste des Petits Ruminants (PPR) Virus in 
Sudan: detection virus isolation and identification , patholgenicity and 
serosurveillence. M. V. Sc. thesis Khartoum: University of Khartoum.   
   
Obi, T.U.; McCullough, K.C. and Taylor, W.P. (1990). The production of 
peste des petits ruminants hyperimmune sera in rabbits and their 
application in virus diagnosis. J.Vet. Med. Series B. 37 (5): 345-352. 
Obi, T.U.; (1984). Serological studies with peste des petits ruminants and 
rinderpest viruses in Nigeria Trop. Anim .Health Prod, 16 (1): 115-118. 
 
OIE, (2000). (Office International des Epizooties/World Organization for 
Animal Health).Peste des petits ruminants .In: Manual of standards for 
diagnostic tests and vaccines .Ed 4. Chap 2.1.5.pp1-14 
 
OIE, (2002). (Office international des Epizooties/world organization for 
Animal Health). Peste des petits ruminants. Technical disease card 
database.  
 
Otte, E. (1960). Clinical studies on “abu nini” in the Sudan: a contagious 
disease of goats and sheep possibly caused by a pleuropneumonia-like 
organism. Vet. Rec., 72: 140–145. 
 
Ozkul, A; Akca, Y; Alkan, F; Barrett, T; Karaoglu T. (2002). Prevalence, 
distribution, and host range of peste des petits ruminants virus, Turkey. 
Emerge Infect. Dis., 8(7):708-12. 
 
Pawaiya, R.V.S.; Misra, N.; Bhagwan, P.S.K. and Dubey, S.C. (2004). 
Pathology and distribution of antigen in goats naturally infected with 
peste des petits ruminants virus. Indian J. Anim. Sci., 74 (1): 35-40. 
  
Perry, B. D., Randolph, T. F., Mcermott, J. J., Soncs, K. R. and Thornton, 
P.K. (2002).Investing in animal. Health research to alleviate.ILRI 
(International Livestock Research Institute), Nairobi, Kenya, 148 
 
Radostits, O.M.; Gay, C.C.; Blood, D.C. and Hinchcliff, K.W. (2000). Peste 
des petits ruminants. In: Veterinary Medicine, 9th edition .W.B. 
Saunders, London. pp 1077-1079. 
 53
Rasheed, I.E.  (1992). Isolation of PPRV from Darfur State. Thesis for master 
degree Khartoum University, Sudan.  
 
Rima,B.K.;Baczko,K.;Clarke, D.K.;Curran, M.D.; Martin,S.J.; Billeter,M.A. 
and Ter Meulen,V.(1986). Characterization of clones for the sixth (L) 
gene and transcriptional map for morbilliviruses .J.Gen.Virol., 67:1971-
1978.  
 
Roeder, P. L. and Obi, T.U. (1999). Recognizing peste des petits ruminants.  
A field manual. FAO, Rome. 17: 75-81. 
 
Roeder, P. L.; and W. P. Taylor. (2002). Rinderpest. Vet. Clin. N. Am. Food. 
Anim. Pract., 18:515-547. 
 
Roger, F.; Guebre, Y.M.; Libeau, G.; Diallo, A.; Yigezu, L.M. and Yilma, T. 
(2001). Detection of antibodies of rinderpest and peste des petits 
ruminants viruses (Paramyxoviridae, Morbillivirus) during a new 
epizootic disease in Ethiopian camels (Camelus dromedarius). Revue de 
Med. Vet., 152 (3): 265-268. 
 
Roger, F.; Yigezu, L.M.; Hurard , C.; Libeau, G.; Mebratu, G.Y., Diallo, A. 
and Faye, B. (2000). Investigations on a new pathological condition of 
camels in Ethiopia. J. Cam. Prac. Res., 7: 163-165. 
 
Rowland, A. C. and Bourdin, P. (1970). The histological relationship between 
peste des petits ruminants and kata in West Africa. Revue d’Elevage et de 
Medicine Veterinaries des Pays Tropicaux, 23: 301–307. 
 
Rowland, A.C.,Scott,S. Ramachardran, and Hill, D.H. (1971).Comparative 
study of peste des petits ruminants and Kata in west Africa dwarf goats 
.Trop.Anim .Health Prod.,3:241-245. 
 
Saliki, J A. (1998).Pest des petits ruminants virus, In: US Animal Health 
Association, committee on Foreign Animal Disease. The Gray Book .Ed 
6.part IV. Richmond, VA: US Animal Health Assoc. 
   
Saliki, J.T.; Libeau, G.; House, J.A.; Mebus, C.A.; and Dubovi, J. (1993). 
 54
     A monoclonal antibody based blocking ELISA for specific detection and 
titration of peste des petits ruminants antibody in caprine and ovine sera. 
J. Clin. Microbiol., 31: 1075–1082. 
 
Saliki, J.T.; Brown, C.C.; House, J.A. and Dubovi, E.J. (1994). Differential 
immunohistochemical staining of peste des petits ruminants and 
rinderpest antigens in formalin-fixed, paraffin-embedded tissues using 
monoclonal and polyclonal antibodies. Journal of Veterinary Diagnostic 
Investigation., 6 (1): 96-98. 
 
Saliki, J.T.; Cooper, E.J. and Gustavson, J.P.(2002).Emerging morbillivirus 
infections of marine mammals: Development of two diagnostic 
approaches. Ann. N.Y. Acad.Sci.,969:51-59. 
   
Scott, G.R., (1981). Rinderpest and peste des petits ruminants. In: Virus 
Diseases of Food Animals, Vol. II, Gibbs, E.P.J. (Ed.). Disease 
Monographs. Academic Press, New York, pp. 401–425. 
 
Shaila, M.S.; Purushothaman, V.; Bhasavar, D.; Vnugopal, K. and 
Venkatesan, R.A. (1989).Peste des petits ruminants in India .Vet Rec., 
125:602. 
 
Shaila, M.S.; Shamaki, D.; Forsyth, M.A.; Diallo, A.; Goatley, L.; Kitching, 
R.P. and Barrett ,T .(1996).Geographic distribution and epidemiology of 
peste des petits ruminants virus .Virus Res., 43 (2):149-153. 
 
Singh, R.P.; Sreenivasa, B.P.; Dhar, P. and Bandyopadhyay, S.K. (2004). A 
sandwich-ELISA for the diagnosis of peste des petits ruminants infection 
in small ruminants using antinucleocapsid protein monoclonal antibody. 
Arch. Virol., 149, 2155– 2170. 
 
Singh, R.P.; Sreenivasa, B.P.; Dhar, P.; Roy, R.N. and Bandyopadhyay, 
 S.K. (2000). Development and evaluation of a monoclonal antibody 
based competitive enzyme-linked immunosorbent assay for the detection 
of the rinderpest virus antibodies. Rev. Sci. Tech. Off. Int. Epiz., 19:754–
763. 
 
 55
Singh, R.P. (2002). Production and characterization of monoclonal 
antibodies to peste des petits ruminants virus. . Ph.D. thesis Deemed 
University IVRI, India. 
 
Sreenivasa, B.P.; Dhar, P.; Singh, R. P. and Bandyopadhyay, S.K (2002). 
      Development of peste des petits ruminants (PPR) challenge virus from a 
field isolate. Indian Virological Society, January 18–20 
 
Taylor, W.P.;  Diallo, A.;  Gopalkrishna, S.; Sreeramalu, P.; Wilsmore, A.J.; 
Nanda, Y.P.; Libeau, G.; Rajasekhar, M.; and Mukhopadhyay, A.K., 
(2002). Peste des petits ruminants has been widely present in southern 
India since, if not before, the late 1980s. Prev. Vet. Med., 52: 1–8. 
 
Taylor, W.P.; Diallo, A.; Gopalakrishna, S.; Sreeramalu, P.; Wilsmore, A.J.; 
Nanda, Y.P.; Libeau, G.; Rajasekhar, M. and Mukhopadhyay, A.K. 
(2001). Peste des petits ruminants has been widely present in southern 
India since, if not before, the late 1980s. Prev. Vet. Med., 52 (3-4): 305-
312. 
 
Taylor, W.P. and Abegunde, A. (1979).The isolation of peste des petits 
ruminants virus from Nigerian sheep and goats. Res.Vet.Sci., 26:94-96. 
 
Taylor, W.P. (1984).The distribution and epidemiology of peste des petits 
ruminants .Prev.Vet.Med., 2:157-166. 
 
 Taylor, W.P.; Al Busaidy, S.; and  Barrett, T. (1990). The epidemiology of 
peste des petits ruminants in Sultanate of Oman. Vet. Microbiol., 22: 
341–352. 
 
Wamwayi, H.M.; Rossiter, P.B.; Kariuki, D.P.; Wafula, J.S.; Barrett, T.,and 
Anderson, J. (1995). Peste des petits ruminants antibodies in east Africa. 
Vet. Rec., 136: 199–200. 
 
Whiteny,J.C.;  Scott,G.R. and Hill, D.H.(1967).Preliminary observations on a 
stomatitis and enteritis of goats in southern Nigeria .Bulletin of Epizootic 
Diseases of Africa, 15:31-41. 
 
 56
Zeidan, M. (1994). Diagnosis and distribution of PPR in small ruminants in  
Khartoum States during 1992-1994.Thesis for master degree, Khartoum  
Sudan.  
 
Zwart, D.; and Rowe, L.W. (1966).The occurrence of rinderpest  antibodies 
in the sera of sheep and goats in northern Nigeria. Res. Vet. Sci, 7: 504-
511.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 57
Appendices 
Appendix I 
 
 Buffers 
1. Physiological saline (Normal Saline) 0.85% 
NaCl                                            8.5g 
DDW                                       1000 ml 
 The solution was autoclaved at 121 OC for 30 minutes and kept at +4 OC 
until used .The pH was adjusted to 7.2.  
2. Phosphate buffered saline (PBS) 
Solution A     
Na Cl                                               16 g 
K  Cl                                               0.4 g  
Na2 HOP4 (unhydrous)                     2.3 g 
K HPO4                                          0.4 g 
DDW completed to                      1500 ml 
Solution B 
Mg Cl2.6H2O (hydrous)                  0.426 g 
DDW                                             200 ml 
Solution C 
CaCl2 (hydrous)                              0.426 g 
DDW completed to                         200 ml 
Solution A, B and C were autoclaved at 121oC for 30 minutes and left to 
cool. Solution A was added to Solution B then Solution C was added and 
completed to two employed in medium preparation. Liters with sterile 
DDW. Antibiotics were added at the same concentration.  
3. Phosphate diluents (PD) 
Na Cl                                          16.0 g 
KCl                                              0.4 g 
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Na2 HPO4 (unhydrous)               2.3 g 
KHPO4                                      0.4 g 
DDW completed to                 2000 ml 
The solution was sterilized by autoclaving at 121oC for 30 minutes. 
 
Appendix II 
 
 Cell dispersing solutions 
1. Trypsin (7.5%) 
Trypsin powder                 37.5 g 
PD completed to                500 ml 
The solution was sterilized by filtration. 
2. Veresene (5%) 
Veresene                          25 g 
PD completed to             500 ml 
3. Trypsin versene solution  
Trypsin(7.5%)                  6 ml 
Versene (5%)                    4 ml 
PD                                  90 ml 
Trypsin and versene were sterilized by filtration. PD was sterilized by 
autoclaving at 121oC for 15 minutes.  
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Appendix III 
 
 Tissue culture media 
1. Growth media 
GMEM   medium to prepare 1x GMEM medium  
GMEM 5x                                 200 ml  
Yeast extracts 1%                        25 ml 
Lactalbumen hydrolysate (x5)      25 ml     
Sodium bicarbonate                    7.5 ml  
Fetal calf serum                         10% ml  
The complete medium was sterilized by filtration, supplemented with 
antibiotic (100 iu/ml Penicillin, 50µg/ml Streptomycin, 10µg/ml 
Gentamycin) and Mycostatin at a concentration of 50 iu/ml and then 
completed to 1 litter with DDW. 
2. Maintenance medium 
Same as growth medium with 5% fetal calf serum. 
 Media additives 
1. Lactalbumin hydrolystate (5%) 
Lactalbumin hydrolystate                 25g 
DDW                                             500 ml 
The solution was sterilized by autoclaving at 121oC for 30 minutes. 
2. Sodium bicarbonate 7.5% (NaHCO3) 
NaHCO3                                       7.5 g 
DDW   completed to                     100ml 
The solution was sterilized by autoclaving at 121oC for 30 minutes. 
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